Discover how Dr. Sheena Menezes and Simple Health Kit are revolutionizing healthcare through community-centered platforms, innovative lab kits, and a strategic partnership with Mark Cuban's Cosplus Pharmacy.

This episode details the vision for equitable access and the integration of technology in healthcare. In this episode: 

• The foundation and mission of Simple Health Kit in providing accessible healthcare
• How the platform partners with enterprises to engage underserved populations
• The significance of Mark Cuban's Cosplus Pharmacy partnership and its impact on medication affordability
• The origin story of Sheena Menezes: from Kuwait refugee to healthcare innovator
• The role of digital and physical channels in delivering health kits and lab testing
• Vision for the future: bringing high-quality, personalized healthcare to rural and underserved areas
• The importance of primary care access, especially in rural health settings
• The influence of technology, including AI and community-focused models, in preventive care

Timestamps:

00:00 - Welcome and overview of Simple Health Kit's mission

00:36 - How Simple Health Kit puts individuals at the center of care

01:43 - Major announcement: partnership with Mark Cuban's Cosplus Pharmacy

02:08 - Benefits of the partnership for medication access and affordability

02:53 - Sheena Menezes' inspiring origin story

03:21 - The drive to bring care to those who need it most

03:53 - The growth and scale of Simple Health Kit over seven years

04:16 - How patients can access Simple Health Kit products via health plans, stores, and online

04:45 - Physical in-store health kits and direct-to-consumer options

05:04 - The range of lab testing available: diabetes, kidney, cancer, STI

05:24 - Strategic channels: payers, providers, and pharmacies

05:28 - Vision for universal healthcare access in the next decade

06:03 - Focus on high-level, concierge care in underserved areas

06:32 - Exciting future developments and Mark Cuban connection

Resources & Links: https://www.simplehealthkit.com/

Connect with Dr. Sheena Menezes:   / sheenamenezes  

Everyone wants to talk about AI in healthcare.
Greg Miller wants to talk about the work no one sees.

In this live conversation from ViVE, Greg Miller, VP at Carta Healthcare, joins the Boombostic Health Podcast to expose one of healthcare's most expensive hidden problems: the billions spent manually abstracting clinical data for registries, quality reporting, accreditation, CMS measures, and benchmarking.

This is not basic data entry. It is highly skilled clinical work. Nurses and clinical experts are digging through EHRs, interpreting complex patient records, and making judgment calls that directly impact how hospitals measure quality and performance. Greg calls it "swivel chair interoperability," and it is costing U.S. healthcare an estimated $10–$15 billion every year.

But the answer is not just "throw AI at it."

Greg makes the case for hybrid intelligence: AI powerful enough to accelerate the work, with clinician oversight strong enough to earn trust. Because in healthcare, accuracy is not optional, workflow matters, and the market is moving past AI hype toward solutions that prove ROI fast.

The real question is no longer whether healthcare will use AI.

It is whether AI can actually solve the messy, expensive, high-stakes problems buried inside the system.

Timestamps

00:00 — Why clinical data abstraction is healthcare's hidden cost center
02:16 — Why registry work still requires clinical judgment
04:37 — The trust gap: why AI needs clinician oversight
05:38 — How Carta Healthcare repositioned around "hybrid intelligence"
10:01 — Why the AI hype cycle is giving way to ROI
11:54 — Why healthcare technology fails when it sits outside the workflow

Best Moments

Greg breaks down why some registry questions cannot be answered by simply searching the EHR. They require clinical inference, context, and expertise.

He also explains why healthcare buyers are getting sharper. A year ago, AI was the shiny object. Now, health systems want practical implementation, workflow integration, and measurable financial impact.

Key Takeaway

AI will not win in healthcare because it sounds impressive.

It will win when it removes burden, protects accuracy, fits the workflow, and earns clinician trust.

That is the promise of hybrid intelligence.

Featured Guest

Greg Miller
VP, Carta Healthcare

Follow Boombostic Health for more conversations with the leaders building the future of healthcare.

Drawing from both clinical experience and hc1's MyBloodHealth technology, Tiffany explains how anemia silently drives up rates of hemorrhage, heart complications, postpartum depression, and even maternal death. And while anemia is often missed in early pregnancy (18% of women in the 1st trimester), it skyrockets to 80% by the 3rd trimester—when it's far harder to manage.

The conversation also dives into the stark racial disparities in maternal outcomes: Black and Native mothers die at a rate of 49.5 per 100,000 births, compared to 19 per 100,000 for white mothers. Tiffany unpacks how fragmented care, lack of early screening, and systemic inequities continue to put mothers and babies at risk—despite being preventable.

But it's not all grim. Tiffany also shares how HerCare powered by MyBloodHealth is giving providers the tools to proactively identify risk, streamline workflows, and deliver better outcomes for both moms and babies.

Guest: Tiffany Hall, Nurse and Director of cPBM Clinical Technology at hc1

What You'll Learn in This Episode

• 📊 The shocking stats: anemia's rise from 18% in the 1st trimester to 80% by the 3rd

• ⚠️ How anemia fuels hemorrhage, cardiovascular problems, and postpartum depression

• ✊ Why Black and Native mothers face mortality rates more than 2X higher than white mothers

• 🧪 How lab-driven insights can flip care from reactive to proactive

• 💡 How HerCare simplifies provider workflows and closes dangerous gaps in maternal care

Why It Matters

Every statistic in this episode represents mothers, babies, and families forever changed. Tiffany's message is clear: maternal deaths and injuries in the U.S. are preventable—but only if we address hidden risks early and make proactive care the standard.

Chapter Highlights:

00:00 – Intro & Guest

01:57 – Tiffany's Background

04:46 – Mothers & Babies at Risk

05:29 – Broken U.S. Care System

08:18 – 49.5 vs 19: The Disparity

10:09 – Hidden Risk: Anemia

11:57 – How HerCare Works

19:23 – Awareness & Policy Change 

22:07 – The Future of Maternal Care

27:56 – Closing & Takeaways

Episode Overview

Key Topics

• Transform your sale from a routine transaction into a strategic masterstroke. Are you truly ready to sell? Crystal shares insights on preparing for a sale, dealing with non-compete clauses, and navigating legal intricacies.

• Explore the hottest segments in healthcare M&A, with a spotlight on laboratory and mental health sectors. Is your sector poised for a boom or a bust? Understand the macro trends influencing the market today.

• Discover why choosing the right partner is more than just a financial decision—it's a strategic necessity that can redefine your future. Learn how to align your vision with potential buyers for maximum impact.

• Navigate the minefield of healthcare regulations with insights that could save your deal from disaster. Are you prepared to tackle the Stark Law head-on? Christal and Emily discuss the importance of compliance and how to avoid common pitfalls.

Healthcare transformation will not happen through technology alone. It will happen when diagnostics, data, clinical workflows, and incentives finally work together.

In this episode of Boombostic Health, Bradley Bostic sits down with Gary Albers and Steve Serota for a practical conversation on how diagnostics can move healthcare from reactive treatment to proactive, value-based care.

The discussion explores why laboratory medicine is often one of the most underutilized levers in healthcare, despite its ability to influence earlier intervention, better medication decisions, lower costs, and more personalized care. Gary and Steve share how health systems, payers, providers, and innovators can use diagnostic intelligence to close gaps in care, improve trust, and create measurable outcomes.

From pharmacogenomics and primary care workflow redesign to AI, biometric monitoring, and payer partnerships, this episode goes beyond theory and looks at what it actually takes to make value-based care work in the real world.

In this episode:

• How diagnostics can drive earlier, smarter, and more cost-effective care
• Why laboratory medicine needs a larger role in value-based healthcare strategy
• Gary Albers on building high-value outcomes through better diagnostic collaboration
• Steve Serota on turning lab data into actionable clinical intelligence
• Why fee-for-service adoption is slow and what is accelerating the move toward value-based models
• How pharmacogenomics and medication optimization can reduce avoidable costs
• The importance of primary care workflows in making diagnostics usable at scale
• How AI and continuous measurement can support more personalized interventions
• Why trust, privacy, and patient engagement matter in a more connected healthcare ecosystem
• The future of healthcare through biometrics, personalized medicine, and integrated care models

Key Takeaways:

• Diagnostics are not just tests. They are decision-making tools that can help identify risk earlier, guide treatment, and reduce waste across the healthcare system.
• Value-based care requires more than new payment models. It depends on better data, stronger workflows, aligned incentives, and measurable clinical impact.
• The future of healthcare will be more proactive, personalized, and data-driven, but adoption will depend on trust, usability, and proving value in real-world care settings.

Timestamps:

00:00 Introduction: Why diagnostics matter in healthcare transformation

01:01 Collaboration as a driver of value-based care

01:34 Gary Albers on high-value diagnostics and laboratory medicine

04:02 Steve Serota on lab data, patient outcomes, and clinical intelligence

07:19 Why value-based care adoption has been slow

08:36 Policy, incentives, and the strategic role of clinical data

10:52 Precision medicine, medication optimization, and cost savings

12:11 Measuring the impact of interventions in real time

14:05 Reimbursement models and the economics of diagnostics

15:01 Funding innovation and upfront investment in value-based care

16:12 Why primary care workflow is critical to diagnostic adoption

19:10 AI, data, and proactive healthcare decisions

22:38 Building trust with more complete patient data

27:43 Biometric monitoring, patient responsibility, and privacy

38:11 Tech giants, health plans, and the future of cost control

44:25 How diagnostics can deliver actionable, affordable outcomes

46:24 Final thoughts: Building the future through collaboration

About Boombostic Health:

Boombostic Health explores the people, ideas, and innovations reshaping healthcare. Hosted by Bradley Bostic, the show brings together leaders across diagnostics, data, AI, value-based care, and healthcare transformation to discuss what is working, what needs to change, and where the industry is headed next.

Healthcare does not need more AI hype.

It needs AI that can survive clinical reality: compliance, governance, patient safety, workflow, physician adoption, and the brutal operational pressure every health system is facing.

In this episode of Boombostic Health, Bradley Bostic sits down live at ViVE 2026 with Matt Cox, Executive Director for Digital Value Creation at Duke Health, to unpack how Duke is moving from AI experimentation to real-world clinical impact.

Matt shares how Duke is building its own AI capabilities, including the Scout LLM platform, to safely support use cases across the health system — from clinical research and chart review to virtual nursing, ambient documentation, operational efficiency, and clinician burnout.

The standout example: Duke used Scout to review 200 pancreatic cancer patient charts in less than two hours — work that would typically take a PA or nurse practitioner one to two weeks.

That is not theoretical AI.

That is capacity creation.

That is clinicians working at the top of their license.

That is the future healthcare actually needs.

In this episode

Bradley and Matt discuss:

• Why Duke chose to build internal AI infrastructure instead of relying only on outside tools

• How Duke evaluates AI through governance, compliance, safety, bias, and clinical decision support

• The role of Duke Institute for Health Innovation and EHRX in exposing health data safely

• How Scout is helping accelerate chart review, clinical research, and protocol compliance

• Why AI's biggest opportunity may be giving time back to clinicians

• Duke's approach to investing in startups that solve real internal health system problems

• The growing importance of virtual nursing, ambient AI, and operating-room intelligence

• Why human factors may determine whether healthcare AI succeeds or fails

• What Matt is watching across the healthcare innovation landscape after ViVE

Key Takeaways

1. The winning health systems will not just buy AI. They will govern it.
Duke is not treating AI as a shiny object. It is building processes to test whether tools are safe, compliant, clinically appropriate, and operationally useful before scaling them.

2. AI only matters if it removes real friction.
The Scout example shows the real promise: not replacing clinicians, but removing time-consuming administrative and review work so highly trained people can focus on patients, research, and care delivery.

3. Innovation starts with the problem, not the pitch deck.
Duke's venture approach begins with internal pain points — nurse burnout, clinician burnout, access, capacity, and workflow — then looks for companies that can help solve them.

Chapters

00:00 — Live from ViVE 2026 with Matt Cox of Duke Health
01:22 — Matt's role leading digital value creation at Duke
04:05 — How Duke built the foundation for healthcare AI through EHRX
05:04 — Why Duke created its own LLM capability
05:52 — Governing AI through safety, compliance, and clinical decision support
07:21 — Inside Scout, Duke's AI platform
08:18 — Reviewing 200 pancreatic cancer charts in under two hours
10:11 — Using AI to free clinicians and expand capacity
11:52 — Duke's shift from reactive innovation to targeted venture investing
12:44 — Why nurse burnout and virtual nursing are top priorities
14:07 — Ambient AI and the fastest adoption Matt has seen in healthcare
15:44 — How Duke prioritizes investment and implementation opportunities
17:42 — What Matt is learning at ViVE: human factors, new roles, and the future of work

Featured Guest

Matt Cox
Executive Director, Digital Value Creation
Duke Health

Mentioned in this episode

• Duke Health

• Duke Institute for Health Innovation

• EHRX

• Scout LLM Platform

• Ambient AI

• Virtual Nursing

• Algorithm-Based Clinical Decision Support

• ViVE 2026

About Boombostic Health

Boombostic Health puts a spotlight on the people, technologies, and ideas moving healthcare forward. Hosted by Bradley Bostic, each conversation explores the practical innovations reshaping care delivery, diagnostics, data, AI, and the future of healthcare.

Subscribe for more conversations with the leaders building what comes next in healthcare.

Show Notes

Hospital alarms are supposed to protect patients. But when nearly every signal becomes background noise, the warning that actually matters may be the one no one hears.

Live from ViVE, Marcus Gordon sits down with Dr. Darren Klugman, Chief Clinical Officer at CalmWave, to examine one of healthcare's most overlooked risks: the growing gap between the volume of hospital data and the human capacity to interpret it.

Dr. Klugman explains why alarm fatigue is more than an operational nuisance—it is a patient safety problem. Clinicians are being asked to manage increasingly complex patients, devices, scores, and alerts while still delivering the human care that technology cannot replace.

The answer is not another dashboard or another point solution. It is a smarter operational foundation that unifies electronic health record and bedside device data, separates meaningful signals from noise, and turns information into recommendations clinicians can act on.

The conversation explores how mathematical modeling and data science can improve patient monitoring, give clinical engineering real-time visibility into device performance, inform nursing resources, forecast patient recovery, and help hospitals move patients through the ICU more safely and efficiently.

For health system executives, the business case is equally clear: reducing preventable harm, shortening length of stay, improving bed utilization, increasing patient throughput, and allowing clinicians to practice at the top of their expertise.

Healthcare does not need to give clinicians more data to interpret. It needs to make the data they already have actionable.

In this episode:

• Why excessive non-actionable alarms can cause clinicians to miss the signals that matter

• How unified hospital data can improve patient safety, staffing, device management, and patient flow

• Why health systems must move beyond disconnected point solutions and demand measurable operational value

• How AI can reduce cognitive burden without replacing clinical judgment

• Why today's workforce and capacity crisis makes smarter hospital operations essential

Timestamps

00:00 — Live from ViVE with Dr. Darren Klugman
00:27 — Unifying EHR and bedside device data
01:38 — When hospital alarms become dangerous background noise
04:20 — Reducing cognitive burden inside the clinical workflow
06:35 — Building one data foundation for hospital operations
08:05 — Patient safety, ICU throughput, and measurable ROI
09:58 — What health systems should demand from technology vendors
12:39 — Why healthcare's workforce and capacity crisis demands action

Subscribe to Boombostic Health for candid conversations with the leaders transforming healthcare through better data, smarter technology, and more accountable innovation.

In this episode of Boombostic Health, Bradley Bostic sits down with Dr. Justin Bekelman, oncologist, co-founder, and CEO of Daymark Health, to discuss how value-based oncology can create a better care model for patients, providers, and health plans. After more than two decades at Penn Medicine, Dr. Bekelman left to build Daymark Health, a company that supports patients receiving active cancer treatment through in-home and virtual care. Daymark partners with health plans and works alongside each patient's oncology team to address clinical, behavioral, and social needs when and where they arise. 

The conversation explores why fee-for-service often fails to support the full cancer journey, why oncology is especially suited for value-based care, and why better care requires more than coordination.

It requires the ability to act. As Dr. Bekelman explains, "Cancer doesn't stop at five o'clock." 

Timestamps

00:00 Welcome and personal connection to cancer prevention

03:01 Dr. Bekelman's background and why patients still fall through the cracks

05:30 What value-based care means in oncology

07:28 Why supportive cancer care is under-reimbursed in fee-for-service

09:17 How Daymark Health partners with health plans

10:32 Supporting patients at home, virtually, and at no additional cost

12:44 Episodic capitation, shared savings, and oncology economics

15:18 Why cancer care is well suited for value-based models

17:24 Daymark as the "connective tissue" around the oncologist

20:34 Why coordination alone is not enough

23:01 Daymark's work with Blue Cross Blue Shield of Rhode Island

24:08 Steven's story and why cancer does not stop at 5 PM

27:37 Patient experience, home visits, and measurable results

30:19 Why this model could become the standard for cancer care

In this episode:

• Why cancer patients need support beyond the clinic
• How value-based care is being applied to oncology 
• Why Daymark works through health plan partnerships
• The difference between care coordination and clinical action
• How in-home care can help prevent avoidable complications
• Why behavioral health and social support matter in cancer treatment
• How better patient support can reduce total cost of care
• Why oncology may be one of the next major frontiers for value-based care

This episode dives into the story of Health Gorilla and its founder, Bob Watson, revealing how innovative approaches are tackling one of healthcare's most persistent problems: data interoperability. With decades of experience, Bob shares strategic insights and the evolving landscape that is shaping the future of healthcare information exchange.In this episode:

• Bob Watson's background at Cerner and lessons from early interoperability efforts
• The evolution of data blocking strategies and shifting industry tactics
• How TEFCA's implementation is creating new momentum for healthcare data sharing
• The core value propositions behind Health Gorilla's platform
• The importance of high-quality, AI-ready healthcare data
• Challenges and opportunities in integrating medical images into electronic sharing
• How legacy systems are connected through Health Gorilla's architecture
• The role of government regulation and penalties in driving compliance
• The vision for a future where healthcare data is seamless, actionable, and patient-centric

Timestamps:00:00 - Introduction to Bob Watson and the origins of Health Gorilla
00:08 - Bob's experience at Cerner and pioneering early health IT initiatives
00:32 - Building the Connected Community and lessons from early EHR adoption
00:58 - Data blocking strategies in the 90s and their impact on interoperability
01:44 - Bob's transition to turnaround leadership and lessons from multiple engagements
02:15 - The importance of the right team and strategic focus for tech companies
02:28 - Narrowing down core customer profiles and target markets
02:43 - Focus on Epic, Cerner, and e-clinical work as key interoperable systems
03:07 - Value-based care and the role of data in Medicare Advantage programs
03:26 - Developing private lab networks and new use cases under TEFCA
03:52 - How TEFCA's implementation increases data exchange traffic
04:21 - Facilitating patient data access and reciprocity in information sharing
04:48 - Industry impact of data blocking lawsuits and regulatory changes
05:13 - The federal push for interoperability akin to the HITECH Act
05:39 - Penalties and non-compliance consequences as enforcement tools
06:01 - Delivering high-quality, actionable data for AI and clinical decision-making
06:23 - Personal story: navigating healthcare data transfer challenges as a patient
06:45 - The future of incentivizing interoperability through economic measures
07:07 - Infrastructure at the endpoints vs. legacy system dependencies
07:25 - Delivering consumable, easy-to-interpret data for busy clinicians
07:53 - Reducing care gaps through comprehensive, uniform health records
08:18 - The importance of high-certainty data for AI training and predictive care
09:02 - How Health Gorilla's curated, accurate data supports advanced AI applications
09:41 - Bob's return from retired life to address relentless interoperability challenges
10:26 - The evolving role of images and challenges in flowing medical imaging data
11:11 - Vendor issues and technical constraints in transmitting medical images
11:27 - The goal to improve data quality and flow from legacy systems like Meditech
11:51 - Connecting all legacy networks for comprehensive data sharing
12:05 - The potential for Health Gorilla to be a significant player in healthcare interoperability
12:29 - The importance of government support—sticks and carrots—in fostering industry change
12:42 - Closing thoughts: the future of seamless, actionable healthcare data

Gene by Gene quietly runs one of the most advanced, high-throughput genomics labs in the world — powering platforms like MyHeritage and rapidly transforming clinical medicine, oncology, pharmacogenomics, and ancestry. 

This conversation explores what happens when every person leaves the hospital with a genomic passport — a lifelong DNA profile they own, control, and use to prevent disease before it begins. This is preventive medicine at scale. Not someday — now.

What You'll Learn

- Why the genomics industry just flipped overnight

- How AI + sequencing will routinely identify disease risk decades early

- What happens when every patient controls their genomic data

- How pharmacogenomics improves medication safety and outcomes

- Why the healthcare system can't keep up with genomic progress 

Chapters

00:00 – Live at HLTH 2025 00:29 – The quiet giant behind global genomics

01:20 – From physician to entrepreneur

02:45 – Acquiring Gene by Gene

04:19 – The massive shift to whole-genome sequencing 

05:59 – Why more data = better diagnosis and prevention 

07:30 – DecisionRx partnership and real-world outcomes

08:19 – Cost, speed, and modularity as the winning edge

09:52 – Sequencing every newborn at birth

11:00 – Data democratization and genomic ownership

11:59 – AI + 3 billion base pairs: why machines must lead

13:24 – Polygenic risk scoring and preventive cardiology

15:38 – Cognitive health and early-intervention models

16:40 – Nutrition + genomics: personal story

17:50 – Sleep, diet & medication metabolism

18:25 – Closing thoughts and future collaboration

Learn more:

https://www.boombostichealth.com/

https://www.genebygene.com/

#genomics #precisionmedicine #boombostichealth #DNARevolution #healthcareinnovation #futureofhealthcare #preventivemedicine #healthtech #biotechnology #artificialintelligence

At HLTH 2025, we sat down with Michael Dalton, CEO and founder of Ovatient, to unpack the real story behind why rural and urban patients alike are falling through the cracks and how Ovatient built the first truly integrated virtual multi-specialty practice on Epic.

This conversation exposes three uncomfortable truths in healthcare:

1. Access is still broken. Millions delay care because transportation, work schedules, stigma, or geography get in the way.

2. Telemedicine wasn't enough. Single-visit, transactional virtual care doesn't build trusted relationships, close care gaps, or keep patients inside a system of care.

3. Health systems are missing billions in preventable leakage. Ovatient's "digital health home" model quietly fixes that.

Dalton breaks down why:
• A virtual-first care model that's integrated directly into Epic makes specialists accessible within hours, not months
• 95% of patients can be supported at home while still remaining inside their health system
• Weight management, behavioral health, primary care, and specialty care all operate seamlessly across one unified patient journey
• Virtual care isn't cannibalizing brick-and-mortar — it's expanding the funnel

If you care about access, equity, referral management, or the economics of keeping patients connected to a system of care… this episode will challenge everything you think you know about "telemedicine."

Ovatient isn't building a digital front door. They're building the digital health home. And it's changing the game.

🎧 Listen now and rethink everything you thought "virtual care" meant.

Chapters

00:00 Introduction to Ovatient and Its Purpose

01:49 The Virtual Multi-Specialty Care Model

05:36 Integration with Health Systems

09:19 Building Trust in Healthcare

12:29 Closing Care Gaps with E-Consults

ixlayer x Sanofi Ventures @ HLTH 2025 Patients don't suffer because we lack medical innovation — they suffer because it takes too long to access it. 

🚀 Why This Matters Patients today are consumers — they expect speed, personalization, and access. Pharma, technology, and venture capital are aligning to deliver it.

The future of healthcare is collaborative, data-driven, and patient-first. Live from HLTH 2025 in the Diagnostic Zone, we dig into the real barriers between patients and lifesaving therapies. This episode covers: 

• How digital platforms reduce barriers to treatment
• How AI is fueling proactive, personalized care
• Why strategic capital accelerates patient-impact innovation

Featuring: Pouria Sanae — Co-Founder & CEO, ixlayer Cris De Luca — Sanofi Ventures ⏱️

Timestamps 

00:00 — Live at HLTH: Rethinking the pharma-patient connection

02:18 — Why patient access is the real bottleneck

04:20 — Sanofi Ventures: inside the strategic innovation model

06:45 — The truth about time-to-treatment in America

08:40 — The evolution of ixlayer & diagnostics infrastructure

10:30 — Can big pharma really go patient-first?

12:00 — Evidence, outcomes & trust in AI + health tech  

Listen & Subscribe Never miss an episode where we challenge the status quo in healthcare and spotlight the innovators building what's next.

Healing Healthcare™ starts with bold ideas — and the courage to build them.

 #healthcareinnovation #digitalhealth #patientaccess #boombostichealth #aiinhealthcare #healthtech #pharmainnovation #futureofhealthcare #hlth2025 #hlthusa #PrecisionMedicine

Amelia shares her 20+ year journey in scientific and clinical research, including a decade in MedTech leading regulatory and clinical affairs. She explains how RWD fills the gaps left by clinical trials, supports post-market surveillance, uncovers off-label use, and even opens the door to label expansion — giving manufacturers faster, less costly ways to prove safety and effectiveness.

The conversation dives into the risks of ignoring RWD, the opportunities it creates for innovation and revenue, and how this shift could save one-third of devices currently at risk of disappearing from the market.

What You'll Learn in This Episode

• Why pre-market clinical trials don't fully reflect everyday device usage.

• How real-world data provides insights into broader and more diverse patient populations.

• Why manufacturers fear off-label data — and how it can actually unlock new markets.

• The importance of treating RWD studies with the same rigor as traditional clinical research.

• How RWD can accelerate innovation, improve patient outcomes, reduce costs, and support regulatory compliance.

Why It Matters
Without embracing real-world data, the MedTech industry risks losing critical devices — some of which save lives in high-stakes scenarios. By shifting mindset and using RWD with scientific rigor, manufacturers can not only ensure patient safety but also unlock growth opportunities, accelerate label expansion, and meet regulatory demands more efficiently.

Resources & Links

• Learn more about 3Aware

• Connect with Dr. Amelia Hufford on LinkedIn

• Follow Bradley Bostic on LinkedIn

• Subscribe on LinkedIn for weekly newsletter

In this special "Best Of" episode, we bring together the boldest, most unforgettable moments from our five most-watched interviews on Boombostic Health. These leaders aren't just talking about change—they're making it happen.

In just 30 minutes, you'll hear from entrepreneurs, investors, clinicians, and health system leaders who are all challenging the business of healthcare in radically different—and deeply personal—ways.

Featured Guests:

• Chris Leeuw – After surviving a paralyzing spinal cord injury, Chris defied the odds, relearned to walk, and launched NeuroHope to build a more humane, patient-focused model of care.

• Adam Heller – Venture capitalist and founder of Oakwood Circle Ventures, Adam breaks down the economic dysfunction at the heart of healthcare and why capital must follow impact, not hype.

• Steve Serota – As a leader in lab medicine, Steve explains why treating cancer without subspecialized pathologists is a dangerous norm—and what needs to change now.

• Matt Honan – A diagnostics executive who reveals how a simple lab test can prevent costly surgical complications, while saving lives and driving smarter care.

• David Ohm – A nonprofit health system executive showing how AI can bring operational efficiency—and better care—to underserved populations, if applied with the right intent.

What You'll Learn:

• Why most spinal cord injury patients are abandoned by the system—and how NeuroHope is changing that

• The trillion-dollar inefficiencies strangling healthcare innovation

• How diagnostics can shift care from reactive to proactive

• The hidden power of pathology—and what happens when we ignore it

• Why AI in healthcare isn't just about tech—it's about equity, governance, and trust

🎧 Listen if you're ready to:

• Hear real solutions from the people building them

• Challenge your assumptions about healthcare innovation

• Get inspired by resilience, purpose, and bold leadership

Show Notes: Boombostic Health Episode 26

Episode Overview:

In this special live episode recorded at the Health Innovation Summit in Indianapolis, Bradley sits down with David Ohm, Chief Strategic Development Officer at MultiCare, to discuss the future of healthcare. From the iconic Indianapolis Motor Speedway to the challenges of AI and data in nonprofit health systems, this episode dives deep into the opportunities and obstacles shaping the industry.

Key Topics Covered:

• High Performance in Healthcare: Drawing parallels between the speed and precision of IndyCar racing and the need for healthcare to move beyond its current inefficiencies.

• David Ohm's Journey: From the Chicago Board of Trade pits to leading innovation in healthcare, David shares lessons in resilience and reinvention.

• AI in Healthcare: Exploring how AI is being used to streamline operations, reduce costs, and improve patient care—while addressing the risks of moving too fast without proper governance.

• The Value of Data: Why raw data isn't enough and how actionable insights, collaboration, and tokenization are the keys to unlocking its potential.

• The Future of Healthcare: A look 10 years ahead—how AI and data could transform patient care, reduce clinician burnout, and create a more transparent, efficient system.

Top Takeaways:

1. AI is Reshaping Healthcare: From automating processes to predictive analytics, AI is already making an impact, but caution and governance are critical.

2. Data Alone Isn't Valuable: Insights and collaboration are what truly drive innovation and better patient outcomes.

3. The Human Factor Matters: While AI can enhance efficiency, the human touch remains essential in delivering holistic care.

Memorable Quotes:

• "Your data alone isn't that valuable—it's the insights and collaboration that make the difference."

• "AI will advance exponentially, but we need to ensure the human element remains primary."

• "Healthcare is at a horse-and-buggy pace, and it's time to tune the knobs for high performance."

What's Next?

Stay tuned for the next segment with Emily, where we'll dive into the legal and regulatory challenges of leveraging data for good.

Listen Now: [Insert Podcast Link]

Join the Conversation:

What do you think about the role of AI and data in healthcare? Share your thoughts and key takeaways in the comments or on social media using #BoombosticHealth.

Special Thanks:

Thank you to David Ohm and all the attendees of the Health Innovation Summit for making this episode possible!

Is anemia the silent disruptor of our nation's health? In this Boombostic Health episode, we reveal how tackling this under-recognized condition could revolutionize chronic disease management. Join expert Jason Carney as he unveils groundbreaking blood management strategies that promise to reshape healthcare.

Key Takeaways:

• Addressing anemia can lead to breakthroughs in managing other chronic diseases.

• Effective blood management strategies can significantly improve patient outcomes and reduce healthcare costs.

• The integration of data-driven tools in healthcare can enhance clinical excellence and economic efficiency.

Episode Highlights:

• Anemia's Hidden Impact: Anemia is a leading cause of reduced quality of life, affecting a third of the nation's population. Despite its significant impact, it often remains under-recognized due to the focus on more prominent chronic diseases. This episode uncovers how addressing anemia can lead to breakthroughs in managing other chronic conditions.

• Introducing Jason Carney: Meet Jason Carney, VP of Clinical Transformation at hc1, whose career includes pivotal roles at the American Red Cross and Suncoast Blood Bank. Jason is the inventor of MyBlood Health, a solution that ensures efficient blood utilization to improve patient health outcomes.

• Blood Management Insights: Jason shares insights into blood transfusions, likening them to liquid organ transplants. He emphasizes the critical importance of ethical and efficient blood use, highlighting how responsible transfusion practices can significantly enhance patient recovery and reduce complications.

• Anemia as a Diagnostic Gateway: Discover how anemia serves as a Trojan horse for other chronic diseases, such as chronic kidney disease and congestive heart failure. By addressing anemia, healthcare providers can identify and manage these conditions more effectively, improving overall patient care.

• Innovative Solutions with MyBlood Health: Explore how MyBlood Health leverages data to revolutionize chronic disease management. This innovative tool helps clinicians quickly identify anemia and related chronic conditions, facilitating timely and effective treatment plans that enhance patient outcomes and reduce healthcare costs.

• Economic Impact of Clinical Excellence: Learn about the substantial economic benefits of improved chronic disease management. Jason discusses how MyBlood Health has already saved health systems hundreds of millions of dollars by optimizing blood management and test stewardship, paving the way for future advancements in precision medicine.

Join us for an insightful conversation with Jason Carney as we delve into the transformative potential of innovative blood management strategies and their role in reshaping healthcare. 

Learn more about "The laboratory is the key to improving health outcomes."

See how hc1's Clinical Excellence solutions enhance patient care and save costs.

Welcome to another episode of Boombostic Health in the Wild, recorded live from the JPMorgan Healthcare Conference 2025. Join us as we engage with Adam Mendelsohn, CEO of Vivani Medical, Inc., to explore pioneering advancements in healthcare and the future of obesity treatment.

In this episode, we cover:

• Adam's Journey into Healthcare: Discover how Adam's early exposure to medical device companies, influenced by his father, set the stage for his career in healthcare innovation. Learn about his experiences at MiniMed and how they shaped his entrepreneurial path.

• GLP-1 Medications: Understand the significance of GLP-1 medications in combating obesity and diabetes. We discuss their mechanism, benefits, and the challenges of medication adherence that Vivani aims to address.

• Vivani's Innovative Implant Technology: Dive into Vivani's groundbreaking implant technology designed to enhance medication adherence. Learn how this small implant offers a six-month treatment solution, potentially transforming patient care and health outcomes.

• The Obesity Epidemic: Engage in a thought-provoking discussion on the obesity crisis, the role of lifestyle changes versus medication, and the societal factors influencing health behaviors. Explore the potential of GLP-1 as a catalyst for sustainable lifestyle changes.

• Market Opportunities and Business Insights: Gain insights into the GLP-1 market, valued at $50-$60 billion annually, and the business potential of Vivani's innovations. Understand the regulatory pathways and the financial implications of bringing new healthcare solutions to market.

Tune in to discover how these innovations are shaping the future of healthcare, offering hope and solutions for obesity and diabetes management. Perfect for healthcare professionals, innovators, and anyone interested in the cutting-edge of health tech!

In this episode of Boombostic Health, host Bradley welcomes Michael Zaccaro, a pioneering entrepreneur in the healthcare industry. Michael shares his journey from delivering beer and working in a lumberyard to founding Pharma Logistics, a leader in reverse pharmaceutical distribution. Discover how Michael stumbled into healthcare, the challenges he faced, and the pivotal moments that shaped his business.

Key Discussion Points:

• Michael's Background: From manual labor to healthcare entrepreneur, Michael's unexpected path to success.

• Reverse Pharmaceutical Distribution: Understanding the niche industry and its impact on reducing waste in healthcare.

• Entrepreneurial Journey: The importance of systems, processes, and people in building a successful business.

• Growth and Challenges: Navigating crucial decisions, including securing a Department of Defense contract and automating operations.

• Private Equity Transition: Michael's experience with private equity, the sale process, and the importance of finding the right partner.

• Future of Pharma Logistics: Insights into the evolving industry and the role of data and technology.

• Life After Exit: Michael's new pace of life, investing in other ventures, and maintaining a board role.

Guest Bio:

Michael Zaccaro is the founder of Pharma Logistics, a company specializing in reverse pharmaceutical distribution. With over 27 years of experience, Michael has grown his business from a small startup to an international player. He now focuses on investing and supporting other entrepreneurs.

Connect with Us:

• Website: Boombostic Health

• Social Media: Follow us on YouTube and LinkedIn

Listen and Subscribe:

Catch this episode and more on Apple Podcasts, Spotify, or your favorite podcast platform.

This evolution presents significant challenges for an industry where operational continuity can mean the difference between life and death. Unlike other sectors, healthcare organizations face unique pressures. When systems are down, it's not just a matter of lost revenue—it's about protecting lives. For example, losing access to patient records in an emergency setting can have catastrophic consequences, making healthcare institutions particularly likely to comply with ransom demands.

The vulnerabilities in the healthcare sector are often exacerbated by reliance on outdated infrastructure. Many organizations depend heavily on a small number of vendors, some of which have legacy systems that are difficult to secure. This overreliance creates systemic risks, as any disruption to these vendors can ripple across the entire industry. Diversifying vendor relationships and modernizing technology are essential steps toward mitigating these risks.

To navigate these challenges, healthcare leaders must adopt robust business continuity strategies. This involves planning for disruptions not only within their own systems but also across their supply chains. Regularly testing incident response plans and ensuring redundancies are in place can help organizations recover more quickly from attacks. As one expert noted, business continuity is about preparing for the unexpected, whether it's a ransomware attack, a natural disaster, or a supply chain failure.

Emerging technologies offer promising solutions but also come with their own set of challenges. Blockchain, for instance, has been proposed as a way to secure medical records through decentralization. While the concept is compelling, its implementation raises questions about accessibility and vulnerability. What happens if a patient loses their access key? Or if a large-scale attack compromises the network? These are the kinds of issues healthcare leaders must consider when exploring new technologies.

In addition to technical strategies, leaders must stay ahead of the rapidly evolving regulatory landscape. Consumer health data, particularly from wearable devices, is generating unprecedented amounts of information. Unlike traditional medical records, much of this data exists outside the protections of HIPAA. While federal and state laws are beginning to address these gaps, the regulatory framework remains a patchwork, leaving room for ambiguity and risk.

Proactive governance is critical. Healthcare organizations must ensure they are not only compliant with existing laws but also adopting ethical practices around data usage. This includes educating patients about how their data is collected and used, as well as implementing strong safeguards to protect against breaches.

The growing intersection of healthcare and consumer technology also presents opportunities for innovation. Wearable devices and AI-powered analytics are enabling more personalized care, from early detection of chronic conditions to real-time health monitoring. These advancements could revolutionize the industry, but they require careful integration with existing systems to avoid creating new vulnerabilities.

Healthcare is racing to be "AI ready." But most of the industry is still trying to turn billing exhaust into strategy.

In this episode, Bradley Bostic sits down with Ryan Leurck, Co-Founder & Chief Analytics Officer at Kythera Labs, to cut through the noise and get blunt about what actually makes AI work in healthcare.

Because the truth is simple—and uncomfortable:
If your data can't be trusted by humans, it can't be trusted by AI.
And in healthcare, much of our data was never designed for the questions we're now demanding it answer.

Takeaways

• Why claims, EHR, and lab data weren't built for strategy—and how that limits AI.
• The risk of modern AI: "AI is not always right, but it always sounds sure."
• Why healthcare data is still optimized for coding and billing, not predictive insight.
• Kythera's mission to "reduce the uncertainty in the use of healthcare data."
• How leaders should think about "AI ready" without falling for hype.
• The reality of claims: a "big bag of receipts" that can mislead without expert context.
• Why data quality and missingness matter as much as the data you do have.
• A practical vision for AI inside provider orgs: agents that function like analysts/interns, not decision-makers.

Chapters

00:00 Introduction to AI in Healthcare
01:23 Ryan Leurck's Journey from Aerospace to Healthcare
03:22 The Current AI Landscape and Its Misconceptions
06:54 Kythera Labs: Reducing Uncertainty in Healthcare Data
11:13 Challenges of Healthcare Data and AI Integration
18:03 Opportunities for AI in Healthcare
22:52 Kythera's Target Audience and Solutions
27:41 The Role of AI in Operational Efficiency
31:18 Data Privacy and Accessibility in Healthcare
34:30 The Future of AI in Healthcare

Keywords

AI, healthcare, data analytics, machine learning, healthcare technology, Kythera Labs, artificial intelligence, data quality, healthcare providers, operational efficiency

Simon's journey from Olympic pole vaulter to AI innovator is remarkable in itself. But it's his insights into how generative AI can revamp clinical trials that truly set him apart. He explains how AI has evolved, not just as a buzzword but as a game-changing force that redefines what's possible in healthcare. Ryght AI's approach is to simplify and accelerate clinical research by connecting all the moving parts involved, creating a platform that benefits from each new advancement in AI without the technical "debt" that usually accompanies such innovation.

One of the most significant obstacles in clinical research is data fragmentation. Many biotech firms lack access to real-time data, making it difficult to connect the right patients with the right trials. Simon elaborates on how Ryght AI leverages generative AI to bridge this gap, creating a network that can process data from various sources, making trial recruitment faster and more precise. Bradley, a strong advocate for personalized care, was quick to highlight the urgent need for such a transformation. "There's a reason AI is essential here—it could mean years shaved off in bringing life-saving drugs to market," Bradley emphasized.

Simon's vision for AI goes beyond mere data processing. He explains that AI enables a more holistic approach, where clinical trials are no longer bound by outdated methods, such as manually matching patient profiles with trials. Instead, AI can predict which clinical trial sites will succeed based on historical data, patient demographics, and existing workloads. This way, clinical trials aren't just fast-tracked; they're also more effective. As Simon puts it, "We're looking to create a future-proof platform that can adapt to new AI models and leverage data without re-engineering the wheel."

The conversation then shifts to the human element in AI-driven healthcare. Simon recounts how AI, if used correctly, could reduce the burnout that often affects doctors and researchers by automating repetitive tasks and allowing them to focus on direct patient care. He imagines a future where AI doesn't replace human judgment but enhances it, giving medical professionals the time and data to make better-informed decisions.
One of the key points Simon raised was the necessity of keeping AI adaptable. Ryght AI's platform sits above the shifting landscape of AI models, allowing it to incorporate the latest and best models without a massive overhaul each time. This adaptability, as he argues, is crucial for any healthcare company looking to stay relevant. In response, Bradley acknowledged the unique challenges and pointed out that "AI in healthcare isn't just a trend; it's a strategic advantage for those ready to evolve."

In closing, Bradley expressed admiration for Ryght AI's mission, describing it as a "turbocharger" for clinical research. With the support of healthcare giants and innovative AI, Simon is optimistic about a future where clinical trials are faster, more accessible, and far more accurate. He envisions a time when life-saving treatments are developed not in decades but in years, a transformation he believes AI will make possible.

This silent killer still kills 75% within the first year of diagnosis. But what if we could spot clues before it becomes deadly?

Transforming Pancreatic Cancer Detection with Amplified SciencesIn this episode, Bradley Bostic hosts Diana Caldwell, CEO and co-founder of Amplified Sciences, to explore groundbreaking advancements in early detection of pancreatic cancer. Given the devastating prognosis of late-stage diagnosis, their discussion highlights how innovative diagnostics can shift the paradigm towards earlier, less invasive screening—saving lives and improving outcomes.Main insights:

• The dire statistics of pancreatic cancer survival rates highlight an urgent need for better screening.
• Amplified Sciences has developed a multi-omics approach that detects precancerous cysts, much like colon polyps, allowing preemptive intervention.
• The current standard, often reactive, diagnosis leads to late-stage detection; the new method aims to identify risks before symptoms appear.
• They discuss the importance of high negative predictive value (NPV) to rule out malignancy non-invasively.
• The platform uses minimal cyst fluid — only 10 times less than existing tests — crucial for small lesions.
• The approach combines various biomarkers (proteomic, enzymatic, genetic) to improve accuracy.
• Blood-based screening for early detection remains challenging, but amplification of fluid samples offers more precise insights.
• Regulatory milestones, like CAP accreditation, position Amplified Sciences for wider clinical adoption.
• Payer and coverage discussions are ongoing but vital for making this technology accessible.
• The episode emphasizes how technological innovation, multidisciplinary collaboration, and early detection can revolutionize pancreatic cancer care.

Timestamps: 00:11 - Introduction and personal story highlighting the importance of early cancer detection
01:08 - Diana Caldwell's background and motivation to improve gastroenterology diagnostics
04:38 - The science behind Amplified Sciences' diagnostic platform and research origins
07:27 - Current challenges in pancreatic cancer diagnosis and the limitations of standard tests
09:18 - Understanding the brutal statistics and silent progression of pancreatic cancer
10:12 - How genetic factors and incidental screening can identify high-risk individuals
12:41 - The patient journey: from incidental detection to invasive procedures and unmet needs
14:15 - The role of the PANSIS Pro test, regulatory milestones, and sample requirements
16:03 - Differentiating between benign cysts and pre-malignant lesions like IPMN
17:24 - The significance of multi-omic diagnostics and reducing unnecessary surgeries
21:18 - Screening strategies: incidentally detected lesions and the importance of size and location
24:04 - Limitations of current biomarkers like CA 19-9 and the promise of multi-marker panels
26:02 - The unique approach of liquid-focused diagnostics versus traditional blood tests
29:18 - Reimbursement hurdles and the importance of demonstrating clinical utility
32:13 - The mental health impact of uncertain diagnoses and proactive testing benefits
33:55 - The vision for a future where early detection becomes routine and standard careResources & Links:

Resources & Links: Amplified Sciences Official Website: https://amplifiedsciences.com/

Connect with Diana Caldwell on LinkedIn: https://www.linkedin.com/in/dianathompsoncaldwell/

This episode underscores the power of innovative diagnostics to intercept pancreatic cancer early, transforming a deadly prognosis into manageable health outcomes. It highlights the collaborative effort needed across research, regulation, and healthcare platforms to ensure these breakthroughs reach patients.

In this follow up episode, Bradley Bostic talks with Chris Leeuw, CEO of NeuroHope, about the "rehab cliff" facing spinal cord injury, brain injury, stroke, and MS patients when they leave inpatient care and quickly run out of covered visits.

Chris shares what NeuroHope is building in Indianapolis to keep recovery going: a model that blends skilled therapy, trained kinesiologists, adaptive fitness, and a true community so patients can continue progressing long after insurance stops paying.

They also unpack the expanding vision behind the Driven Neuro Recovery Center, developed with the Conquer Paralysis Now, and why this kind of recovery ecosystem is becoming essential infrastructure for the disability community.

In this episode, you'll learn

• Why "30 visits" is not neuro recovery

• How NeuroHope makes long term therapy more affordable after coverage runs out

• What's changed since last year including 30 percent growth in services

• Early outcomes from a two year study tracking complications and readmissions

• Why community is often the difference between surviving and thriving

• What's emerging in rehab tech including trans spinal stimulation and what it could unlock

• The bigger campus vision and what partners could help make possible

  ---

  Help NeuroHope close the rehab gap

  If you believe recovery should not end when insurance does, here are three simple ways to help:

  1. Watch and share this episode
     Send it to one person navigating stroke, spinal cord injury, or brain injury recovery, or to a clinician who needs a better option to refer to.

  2. Support NeuroHope's mission
     NeuroHope relies on community support to keep long term therapy accessible after coverage runs out. If you're able, consider donating or becoming a sponsor.

  3. Partner in Indianapolis
     NeuroHope is building a broader recovery ecosystem and is looking for aligned partners across adaptive sports, mental health, vocational rehab, DME, and innovative rehab technology.

     Guest

     Chris Leeuw is the CEO of NeuroHope, focused on expanding access to long term neuro recovery through therapy, wellness, and community.

   

• View the NeuroHope Wellness Center: https://www.youtube.com/watch?v=0k5p3kLL2_A
• Learn more about NeuroHope: https://www.neurohopewellness.org/

Guest: Scott Jarred, CEO and Founder of Invst

Topic: The Intersection of Health and Wealth

Summary:

In this episode, we dive into the unique approach of Scott Jarred and his company, Invst, which emphasizes a holistic view of financial management. Scott shares his journey from growing up with limited resources to becoming a Wall Street Journal bestselling author and a leader in wealth management.

His new book, Accelerate: How to Reach Financial Freedom Faster So You Can Live the Life You Want, offers six key principles for achieving financial freedom.

Key Points:

• Holistic Wealth Management: Scott discusses the importance of looking beyond traditional investments like stocks and focusing on a comprehensive view that includes private companies and personal health.

• Health and Wealth Connection: The episode explores the correlation between health and productivity, emphasizing that financial success is intertwined with physical well-being.

• Daily Habits for Success: Bradley and Scott share their routines, including workouts and cold showers, as essential habits for maintaining energy and focus.

• Invst's Unique Approach: Scott introduces his firm, Invst, which acts as a personal trainer for your finances, ensuring that every dollar is strategically employed.

• Functional Medicine and Financial Planning: The conversation highlights the parallels between managing health and wealth, advocating for proactive measures in both areas.

• Retirement Reimagined: Scott challenges traditional notions of retirement, advocating for a "work optional" lifestyle where passion and purpose drive continued engagement.

• IndyCar Sponsorship: Invst's sponsorship of an IndyCar team is discussed as a metaphor for high performance and teamwork in both racing and financial management.

Takeaways:

• Prioritize health as a critical component of financial success.

• Develop daily habits that support both physical and financial well-being.

• Consider a holistic approach to wealth management that includes personal growth and health.

• Reevaluate the concept of retirement, focusing on lifelong engagement and purpose.

Pick up a copy of Scott Jarred's book,  Accelerate: How to Reach Financial Freedom Faster So You Can Live the Life You Want, to explore the six principles for financial freedom. 

Chapters

00:00 Introduction to Healthcare Innovation
01:56 Leadership and Organizational Values
04:50 Flagship Hospital Project Overview
08:18 Optimism in Healthcare
12:08 Technology and AI in Healthcare
17:40 Philanthropy and Community Impact
23:13 Data Utilization in Healthcare
28:37 Personalization of Healthcare Experience
34:53 Future of IU Health and Closing Remarks

In this episode of the Boombostic Health podcast, host Bradley Bostic interviews Dennis Murphy, CEO of IU Health, discussing his extensive experience in healthcare leadership, the importance of organizational values, and the innovative projects at IU Health, including a new flagship hospital. They explore the optimism surrounding advancements in healthcare technology, the role of philanthropy in enhancing patient care, and the significance of data aggregation in improving health outcomes. The conversation emphasizes the need for personalized healthcare experiences and the future of healthcare delivery.

Takeaways

• Dennis Murphy has a diverse background in healthcare leadership.
• Organizational values are crucial for guiding employee behavior.
• Philanthropy plays a significant role in enhancing healthcare programs.
• Technological advancements are improving patient outcomes significantly.
• Data aggregation is essential for effective healthcare delivery.
• IU Health is focused on attracting top talent in the healthcare industry.
• The new flagship hospital aims to consolidate resources and improve care.
• Healthcare innovation is driven by both institutional providers and entrepreneurs.
• Personalized healthcare experiences are becoming increasingly important.
• Optimism in healthcare is fueled by ongoing advancements and creative solutions.

Live from ViVE, Marcus Gordon sits down with Dr. Tim O'Connell, co-founder and CEO of Emtelligent and a practicing radiologist, for a conversation about one of the biggest blind spots in modern healthcare: unstructured data.

Dr. O'Connell breaks down why health systems are overflowing with information yet still starving for actionable insight, and why unlocking clinical notes at scale could change everything from patient care to cost control to real-world evidence.

This episode gets into the real tension behind AI in healthcare. The technology is moving fast, but the stakes are too high for blind automation. Diagnoses, claims, treatment decisions, and chart review cannot become black-box exercises. Dr. O'Connell makes the case for clinician-led AI, where humans stay firmly in control and technology does what it does best: surface critical information faster, more accurately, and at scale.

The conversation also explores why radiology has long been seen as a digital pioneer, why AI adoption in clinical workflows may actually be moving faster than in imaging, and what it will take for health systems, payers, and life sciences companies to responsibly share data in ways that improve care without compromising trust.

This is a conversation about where healthcare is actually headed, not in theory, but in practice.

In this episode:

• Why an estimated 80% of healthcare data lives in unstructured clinical notes

• The real reason health systems are data rich but insight poor

• Why human-in-the-loop AI is non-negotiable in healthcare

• How AI-assisted chart review can reduce friction for clinicians

• Why radiology may not be the AI leader people assume it is

• What better data sharing could mean for cost, quality, and real-world evidence

• Why the future of healthcare depends on turning documentation into decisions

Join us for an in-depth conversation with Steve Serota from WDL, as we explore the pivotal role of sub-specialized pathologists in cancer diagnosis and treatment. This episode delves into the strategic importance of advanced laboratory medicine and precision medicine, showcasing how these innovations are reshaping patient care.

We address the challenges of accessing sub-specialists, the economic landscape of pathology, and the transformative potential of digital pathology and AI in healthcare. Steve shares insights into the latest advancements, including the approval of new medications like Plobicto, and discusses the integration of theranostics in personalized medicine.

Watch on YouTube

Key Takeaways:

• Sub-specialized Pathologists: Crucial for accurate cancer diagnoses and the development of innovative treatment strategies.

• Digital Pathology: A revolutionary approach democratizing access to specialized care and setting the stage for AI integration.

• AI in Pathology: Enhances diagnostic precision, extends expert insights globally, and supports better patient outcomes.

• Economic Considerations: The need for pay reform to ensure access to subspecialty pathology and the importance of starting with accurate data.

• Theranostics and Precision Medicine: Combining laboratory medicine with imaging and pharmaceuticals to personalize treatment and improve outcomes.

Healthcare isn't broke because we lack innovation. It's broke because we spend a staggering amount of money moving paper, arguing over rules, and chasing "documentation" instead of outcomes.

From the HC1 booth at Health 2025 in Vegas, Bradley sits down with Fawad—a veteran healthcare data operator turned founder—to talk about the real enemy: administrative waste at trillion-dollar scale… and why slapping GPT on top of messy systems just gives us a confident-sounding parrot.

Penguin AI is building an AI-first healthcare platform designed to run workflows end-to-end across payers and providers—prior auth, revenue cycle, claims, coding, and more—without forcing teams to become AI engineers.

What you'll hear in this episode

• Why "AI in healthcare" is mostly theater if your data is fragmented, dirty, and politically guarded

• The uncomfortable truth: administration is the cost center eating the system alive

• Why GPT can sound brilliant and still be dangerously wrong ("a very smart fairy")

• The case for healthcare-specific platforms (not generic clouds + hope)

• Why "payer vs provider" is an outdated segmentation—and processes prove it

• Founder reality: leaving big-title comfort for the zero-to-one grind

• The Penguin story: branding that grabs attention and signals how hard healthcare change really is

Key takeaways

1) If your AI strategy starts with a chatbot, you're already late.
Start with the workflow. Start with the administrative bottlenecks. Then decide what intelligence belongs inside.

2) "Dr. GPT" is confident, not accountable.
Fawad's warning is simple: models generate plausible language from what they've seen. In healthcare, plausible can still be wrong—and wrong has consequences.

3) The real prize isn't automating tasks. It's removing friction across the payer–provider boundary.
Prior auth doesn't "belong" to one side. Neither does claims. Neither does adjudication. The process crosses the membrane—so the platform has to, too.

4) Healthcare doesn't need more AI demos. It needs clean, longitudinal records and execution.
Better models require better inputs—and partnerships that unlock high-quality, de-identified, longitudinal patient data for real learning (not internet noise).

Notable moments (timestamps)

• 00:00 — Live from Health 2025 in Vegas: meet Fawad, founder of Penguin AI

• 00:26 — From big-company data leadership to startup founder

• 01:48 — The brand: why "Penguin" (and why most tech names are nonsense)

• 04:34 — The core problem: admin work at massive scale (prior auth, claims, RCM, scheduling)

• 06:00 — "Dr. GPT": why it sounds right even when it's wrong

• 07:31 — Funding + momentum: Penguin's Series A and growth

• 08:00 — Building better clinical intelligence requires real healthcare-grade data

• 09:28 — Operator-to-founder: why more insiders need to jump into the arena

• 11:50 — What Penguin actually does: agents, customization, and "platform-level" scale

• 14:05 — Why payer vs provider is a false divide

Who this episode is for

• Health system and payer leaders drowning in prior auth, claims, RCM, coding, and operational drag

• Operators skeptical of hype who want real automation + measurable cost reduction

• Founders building AI in healthcare who are ready to confront the data + workflow reality

• Investors looking for platforms that can win beyond "pilot purgatory"

Call to action

If your team is "doing AI" but still living inside manual workflows, this is your wake-up call:
Stop demo-chasing. Start workflow-owning.

🎧 Watch/listen to the full episode: https://youtu.be/j_Fsuy-BfTM
📌 Learn more about Penguin AI: https://www.penguinai.co

Summary

Ahead of World Anemia Awareness Day (Feb 13), we're resurfacing a timely conversation with Sherri Ozawa, Director of Clinical Operations and Delivery at hc1, on blood health and Patient Blood Management (PBM). We unpack why blood health is often overlooked, where decisions break down in real workflows, and what it takes to make PBM programs stick.

Note: This is an updated video cut. Audio is unchanged from the original release.

In this episode

• PBM in plain English: what it is and why it matters
• Why anemia and iron deficiency are often missed
• Where blood-related decisions break down (screening, handoffs, follow-through)
• What "good" looks like when PBM is built into workflow—not added on
• Practical steps teams can take to improve consistency and execution

About the guest

Sherri Ozawa is the Director of Clinical Operations and Delivery at hc1. She works at the intersection of clinical execution and operational adoption—helping teams turn good ideas into repeatable workflows.

Resources

• World Anemia Awareness Day: https://worldanemiaawareness.com/
• ASPBM: https://aspbm.net/
• CAP TODAY (Aug 2025): https://www.captodaymag.com/captoday/...

Disclaimer This episode is for informational purposes only and is not medical advice.

In this episode of Boombostic Health, Bradley Bostic sits down with Robert Michel, founder of Executive War College and editor-in-chief of The Dark Report, for a wide-ranging conversation on the past, present, and future of laboratory diagnostics.

From the origin story behind Executive War College to the rise of genomics, AI, remote monitoring, and personalized medicine, Robert shares why diagnostics are far more than a line item in healthcare spending. They are one of the most powerful levers for improving outcomes, reducing cost, and helping health systems act earlier.

The conversation explores how lab data can move from being underused information to a strategic asset that supports better decisions across maternal health, chronic disease, medication optimization, aging in place, and preventive care.

In this episode

Bradley and Robert discuss:

• Why the name Executive War College reflects the strategic decisions lab leaders face
• How genomics has evolved from early PCR testing to affordable whole-genome sequencing
• Why diagnostics are central to early detection, patient monitoring, and better outcomes
• How proactive lab-driven interventions can reduce avoidable healthcare costs
• Why lab services are often viewed as a cost center despite their impact on total medical spend
• How labs can become strategic partners by turning data into actionable insight
• The role AI may play in faster, more precise diagnostic decision-making
• How wearables, remote monitoring, robotics, and personalized health data could reshape care
• Why nutrition, microbiome, lifestyle, and prevention are becoming harder to separate from healthcare
• What longevity research and Blue Zones can teach us about healthspan
• Why early adopters and innovation communities matter in advancing healthcare transformation

Key takeaways

Diagnostics are no longer just about test results. They are becoming a strategic intelligence layer for healthcare.

Lab data has the potential to help health systems identify risk earlier, intervene sooner, and reduce avoidable cost.

The future of healthcare will be shaped by the convergence of diagnostics, AI, remote monitoring, personalized medicine, and more proactive care models.

Timestamps

00:00 — Why "Executive War College" became the name and what it signals about lab leadership
02:09 — The evolution of genomics technology since 1995
04:49 — From genetic research to practical diagnostic applications
06:14 — Unlocking the value of lab data for outcomes and cost savings
09:57 — How proactive lab testing can improve maternal and neonatal health
12:56 — Addressing anemia, medication optimization, and other preventable gaps
16:54 — The future of diagnostics, AI, and rapid medical insight
17:43 — Biometric wearables, holistic health, and extending healthspan
20:08 — Nutrition, microbiome, and the shift toward preventive care
25:38 — Lessons from Blue Zones on diet, longevity, and lifestyle
27:24 — Robotics, AI, and aging-in-place care models
32:02 — The future of pharmaceuticals, longevity, and space-age innovation
33:08 — Why innovation communities and early adopters drive progress

That data can expose risk, guide treatment, and give patients greater control over their health. But its value depends on whether it can be connected, understood, and acted on at the right moment.

Live from ViVE 2026, Boombostic Health host Bradley Bostic sits down with Merve Ozkus, Senior Vice President and Chief Information Officer of BioReference Health, for a candid conversation about the changing role of the diagnostic laboratory.

Merve explains how BioReference Health is sharpening its strategic focus while building a more patient-centered technology foundation. She shares why meaningful interoperability requires more than moving information between systems, how consumer-directed testing is changing the relationship between patients and diagnostics, and where artificial intelligence can create real value today.

This is not a conversation about AI replacing clinical judgment. It is about using technology to strengthen the people, processes, and data behind better decisions.

Bradley and Merve discuss:

• Why data is the laboratory's true product
• BioReference Health's strategic evolution and market focus
• What patient-centered interoperability should actually accomplish
• Why patients are becoming more active advocates for their health
• The growing demand for consumer testing and functional medicine
• How BioReference Health is approaching AI responsibly
• Where AI can improve operations without removing human oversight
• Why AI education must become as fundamental as cybersecurity training
• How technology can help an overstretched healthcare workforce serve patients more effectively

The next era of diagnostics will not be defined only by how many tests a laboratory can run. It will be defined by how intelligently healthcare can connect and activate what those tests reveal.

CHAPTERS

00:00 Meet BioReference Health CIO Merve Ozkus
01:08 BioReference Health's strategic evolution
02:19 Why the laboratory's real product is data
04:13 The rise of the empowered patient
05:17 Finding signals beyond a single test result
08:33 Meeting patients where they are
10:06 Consumer testing and functional medicine
11:03 Building a secure, patient-centered foundation
11:41 Taking a disciplined approach to AI
12:46 AI as an accelerant, not a replacement
14:56 Why AI literacy is now essential
16:08 Moving from innovation talk to execution

Subscribe to Boombostic Health for candid conversations with the leaders shaping the future of diagnostics, technology, and patient care.

#Diagnostics #LabData #HealthcareAI #Interoperability #PatientCare #ViVE2026

Lisa's extensive experience, particularly in diabetes care with Roche, gives her insights a grounded credibility. She understands that managing diabetes is about more than just medication. As she puts it, "It was about personalization and helping people find their own version of what good looked like." This isn't an easy path; the transition from standard methods to personalized care requires shifting entire systems and mindsets, something she and Bradley both passionately advocate for.

When managing diabetes, the challenge goes beyond merely prescribing treatments. Lisa discusses her work with Roche in a world where devices and apps are not always integrated. As she explains, many people face "disparate pieces and parts where one diagnostic product didn't talk to the therapeutic product." This lack of connectivity can prevent patients from seeing the full picture of their health. It's here where Lisa saw the potential to change lives—working on models to guide patients toward sustainable behavior changes, which, as she mentions, "feels realistic and something they could accomplish."

For those navigating diabetes, or any chronic condition, this kind of behavioral support is essential. "Diabetes in many situations is a behavioral disease," Lisa says, stressing that while medication is critical, it isn't the full solution. She and Bradley explore how success lies in creating a system where patients are motivated by personal goals—like walking a daughter down the aisle—rather than abstract medical advice. The conversation brings into focus the question: How do we enable patients to take control without overwhelming them?

Bradley's interest in this subject isn't just theoretical. As the founder of hc1, he's been a transformative figure, guiding his company to become a leader in using AI to analyze lab data, ensuring that each patient gets the treatment they need, at the time they need it. His experience underscores the need for an approach that combines empathy with innovation.

One key topic Lisa highlights is the evolution from clinic-centered care to care at home. Technology is paving the way for home diagnostics and telehealth to improve accessibility and outcomes. As Lisa describes, the future of healthcare is not in prescribing more but in enabling patients to "engage the healthcare community that surrounds you." It's a vision where patients work with healthcare professionals in a more collaborative and personalized way—one that doesn't sacrifice individual needs for a one-size-fits-all solution.

As our healthcare system faces shortages of trained professionals and escalating costs, it's leaders like Bradley and Lisa who bring new hope. Their vision of a system where personalized care is accessible and economically viable is a bold reimagining of what healthcare can be. They're not just discussing a concept; they're crafting a blueprint for a future where patients are more empowered, and providers are better equipped to deliver care that truly matters.

The next phase is harder: proving value.

In this episode of Boombostic Health, Bradley Bostic talks with Mike Hollis, co-founder of Optura AI, about what healthcare leaders need to do now: move beyond pilots, cut through AI noise, and focus on the use cases that can actually deliver measurable outcomes.

Mike shares why so many organizations are stuck between excitement and execution, how leaders can evaluate AI maturity, and why the future of healthcare AI may be defined less by token usage — and more by trust, transparency, and accountability.

This conversation gets into the real work behind AI adoption: aligning teams, measuring ROI, building confidence, and choosing where AI can create both business value and societal impact.

Especially in areas like rare disease and underserved conditions, Mike makes the case that AI's biggest opportunity may not be where the hype is loudest.

Watch this episode if you're asking:

How do we know which AI initiatives are actually worth pursuing?
Why are so many healthcare organizations stuck in pilot mode?
What does ROI really look like in healthcare AI?
How do trust, transparency, and behavior change affect adoption?
Where can AI create meaningful impact beyond operational efficiency?

Featured moments:

00:00 — Why Optura AI was built
02:43 — AI's economic and societal opportunity in healthcare
03:13 — Why organizations get stuck in AI decision paralysis
05:47 — The metrics that help prove value
06:56 — From token economics to trust economics
10:18 — Why transparency and behavioral science matter
12:23 — The lesson healthcare leaders cannot ignore: ROI matters

Guest: Mike Hollis, Co-Founder, Optura AI
Host: Bradley Bostic
Podcast: Boombostic Health

Subscribe to Boombostic Health for conversations with the leaders building the next era of healthcare.

At its core, M&A in healthcare is about creating partnerships that improve care delivery and expand access to critical resources. Liz emphasized that every merger begins with purpose—leaders must ask, "How will this benefit the patient?" This question drives not only strategic decisions but also the trust and alignment necessary for a successful transition.

Liz's proven SMSO framework—Stabilize, Mobilize, Stabilize, Optimize—has guided countless organizations through the challenges of integration. The process begins with strengthening both entities before any change occurs, ensuring they can withstand the demands of consolidation. "Stability is non-negotiable," Liz explained. "Without it, even the best opportunities can crumble under pressure."

Once stabilization is achieved, mobilization focuses on the careful execution of the transition. Clear communication and thoughtful planning are vital during this phase. Liz stressed the importance of empathy, particularly when addressing the emotional impact of change on employees. "People are the intellectual capital you're acquiring," she said. "Their buy-in determines the success of the entire process."

Following mobilization, the framework emphasizes restabilizing the combined organization to ensure operational continuity before moving into optimization. "It's tempting to aim for immediate efficiency gains," Liz acknowledged. "But patience pays off—jumping too soon adds unnecessary risk."

Bradley highlighted the significance of cultural alignment in M&A, reflecting on his own experience at hc1. He shared that fostering collaboration between teams and ensuring a values-driven approach were critical to the success of past acquisitions. "Without culture fit, even the most strategic mergers can fall apart," he noted.

Regulatory challenges also play a significant role in healthcare M&A. Liz emphasized the need for thorough preparation, including compliance audits and proactive due diligence. By addressing potential vulnerabilities early, organizations can avoid costly delays and maintain trust with stakeholders.

Throughout the episode, Liz and Bradley stressed the importance of tying every decision back to patient impact. Whether scaling operations or integrating cutting-edge technology, the end goal should always be improving care. This perspective not only drives innovation but also reinforces the mission of healthcare as a deeply human endeavor.

Their discussion underscored that success in M&A isn't just about numbers on a spreadsheet—it's about building something greater than the sum of its parts. Leaders who prioritize vision, empathy, and disciplined execution can unlock the full potential of their partnerships and create lasting value for patients and organizations alike.

• Introduction to Healthcare Denials:
• Discussion on the complexities of healthcare denials, focusing on UnitedHealthcare.
• Exploration of how AI can revolutionize denials management by addressing misunderstandings and policy gaps.
• Guest Introduction:
• Brian Norris shares his background and journey into healthcare, inspired by his grandmother's experiences.
• Overview of MedeAnalytics and its role in optimizing healthcare processes through data-driven strategies.
• AI in Denials Management:
• Potential of AI to streamline processes, reduce errors, and improve patient outcomes.
• Discussion on the challenges of denials management and the role of AI in preventing denials by identifying issues early.
• Value-Based Care:
• Exploration of the concept of value-based care and its impact on healthcare delivery.
• Discussion on the integration of AI in enhancing value-based care models.
• Agentic AI and Future Applications:
• Introduction to agentic AI and its potential applications in healthcare.
• Examples of how AI can assist in mundane tasks, allowing healthcare professionals to focus on high-value activities.
• Regulatory and Legal Considerations:
• Brief mention of ongoing litigation related to AI in healthcare denials.
• Discussion on the importance of transparency and patient inclusion in payer processes.

• AI has the potential to transform healthcare denials management by providing actionable insights and reducing administrative burdens.
• Value-based care models can benefit from AI integration, improving patient outcomes and healthcare efficiency.
• The future of AI in healthcare includes agentic AI, which can automate low-risk tasks and enhance clinical workflows.

• Listeners are encouraged to consider the role of AI in healthcare and explore opportunities for innovation in their organizations.
• For more information on MedeAnalytics and their work, visit their website (https://medeanalytics.com/)

• Dr. Kenny Bozorgi: Entrepreneur and practicing physician in gynecological oncology, founder of a successful ambulatory surgery center business in Chicago.

Episode Highlights:

• Dual Careers: Dr. Bozorgi's journey from a practicing physician to an entrepreneur in the healthcare industry.
• Family Influence: How his father's pioneering work in ambulatory surgery centers inspired his career path.
• Healthcare Evolution: The growth of ambulatory surgery centers (ASCs) from the 1970s to today, now handling 50-60% of outpatient procedures.
• Efficiency and Innovation: The advantages of ASCs in providing focused, efficient, and personalized care.
• Regulatory Challenges: Navigating the complexities of operating ASCs, including the certificate of need (CON) process.
• Private Equity in Healthcare: Discussion on the impact and potential of private equity investments in ASCs.
• Value-Based Care: The role of ASCs in advancing healthcare delivery.
• Future of Surgery: Predictions on the continued growth of outpatient care and the evolving landscape of surgery delivery.

Key Takeaways:

• ASCs offer a more efficient and patient-centered alternative to traditional hospital settings.
• The regulatory environment for ASCs is complex but essential for maintaining quality and safety.
• Private equity presents both opportunities and challenges in the healthcare sector.
• Continuous innovation and adaptation are crucial for the success and growth of ASCs.

Additional Resources:

• Learn more about Dr. Kenny Bozorgi's work and the impact of ASCs on the healthcare system:
• www.900nsurgicalcenter.com and www.linkedin.com/company/magna-health-systems-llc/

Join the Conversation:

• Share your thoughts on the future of ambulatory surgery centers and their role in healthcare transformation.

Contact:

• Follow us on social media for updates and more episodes of Boombostic Health.
• Watch on YouTube: https://youtu.be/KNqqiTG1kMM
• Subscribe on LinkedIn: https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7259254152554250241

Recorded live at ViVE in the Diagnostic Zone, Eliad sits down with Jay Sidgreaves of New Day Diagnostics to talk about ColoHealth, an FDA-approved blood-based colorectal cancer screening test designed to help close one of the most urgent gaps in healthcare: getting more people screened before it is too late.

Jay explains why FDA approval matters, why accessibility matters even more, and how diagnostics is moving toward a future where consumers play a much more active role in their care. This conversation also gets into where healthcare is headed next, from blood-based testing and digital platforms to AI-enabled patient education and a more consumer-driven diagnostic experience.

This is not just a conversation about one test. It is a conversation about where diagnostics, prevention, and patient behavior are heading next.

What this episode covers:

• Why colorectal cancer screening remains a major gap in healthcare
• Why blood-based testing could improve access and participation
• What FDA approval signals to patients, providers, and markets
• How consumer-driven diagnostics are changing healthcare
• Why digital health and AI will reshape the patient experience

But Nancy Wright of GE HealthCare makes a sharper point: AI will only be as useful as the infrastructure underneath it.

In this episode of Boombostic Health, recorded live at ViVE 2026 in Los Angeles, Bradley Bostic sits down with Nancy Wright, VP of Digital Platforms at GE HealthCare, for a practical conversation about interoperability, cybersecurity, connected devices, workforce shortages, and the operational future of healthcare.

Nancy explains why interoperability is no longer just about exchanging clinical data. Health systems now need a more connected view across operations, finance, clinical workflows, biomedical engineering, supply chain, and cybersecurity.

The challenge is not replacing every system. It is creating a smarter data layer that allows existing platforms to keep working while giving leaders better visibility, stronger security, and more actionable intelligence.

The conversation also explores why healthcare cybersecurity must become proactive, why connected devices are expanding the risk surface, and how agentic AI could help reduce the burden on clinical and technical teams already stretched thin.

This is a conversation about what healthcare needs before AI can truly scale: connected infrastructure, secure data, and operational intelligence.

In This Episode

Bradley and Nancy discuss:

• Why healthcare's AI future depends on the data layer beneath it
• What interoperability really means inside modern health systems
• Why disconnected operational, clinical, and cybersecurity data creates risk
• How connected devices and IoT endpoints are changing healthcare cybersecurity
• Why health systems need proactive security partners, not reactive fixes
• How agentic AI could support biomedical, clinical, and operational teams
• Why partnership will matter as healthcare innovation accelerates

Key Moments

00:00 — Welcome from ViVE 2026 with Nancy Wright of GE HealthCare
01:08 — How AI is changing operations, labor, and interoperability
03:20 — Why interoperability needs a clearer definition
05:28 — Building a smarter layer across existing health system platforms
06:31 — Cybersecurity, bad actors, and healthcare's growing risk surface
08:48 — Connected devices, IoT endpoints, and proactive risk planning
12:09 — Why ViVE creates momentum for healthcare partnerships
14:15 — Agentic AI, workforce shortages, and the future of healthcare operations

Why It Matters

Healthcare does not need more disconnected technology.

It needs infrastructure that helps leaders see across the enterprise, secure connected assets, support overloaded teams, and turn fragmented data into action.

That is the foundation required for AI to become more than hype.

That's where DecisionRx comes in. Their coined Medication Therapy Optimization (MTO) approach goes far beyond Pharmacogenetics (PGx), combining AI-powered insights with pharmacist-led care to stop the guesswork, lower risk, and deliver results at scale.

In this episode, host Bradley Bostic sits down with Mike Tilton, Chief Growth Officer at DecisionRx, to unpack the problem and spotlight the fix that's delivering:

• 8–10% reduction in total healthcare costs

• 94% patient satisfaction

• Maximum savings with minimal abrasion

"The $528B isn't in pill prices. It's in ER visits, hospital admissions, and complications that never had to happen." — Mike Tilton

What You'll Learn

• Why $528B is being lost annually to preventable medication mismanagement.

• How DecisionRx's MTO model fixes the problem holistically — not just by swapping pills.

• Why ER visits, hospitalizations, and complications drive the real costs.

• Randall's story: from 18 prescriptions and $12K/month to a sustainable regimen that restored his health.

• How DecisionRx's shared-savings model makes adoption possible even for financially strapped health systems.

Medication mismanagement is killing us. DecisionRx has the fix.
👉 Learn more at decisionrx.com

Subscribe to Boombostic Health for bold conversations that expose healthcare's failures — and the solutions that can finally change it.

Healthcare keeps talking about AI, affordability, and outcomes…
But most systems are still ignoring the front door that drives care decisions: diagnostics.

Recorded In the Wild at HLTH 2025 in Las Vegas, Bradley Bostic sits down with James York (Chief Commercial Officer + Head of Government Affairs, Molecular Testing Labs) to unpack a hard truth:

If you can't make testing accessible, convenient, and trackable… you can't build reliable care pathways.

In this episode, James breaks down why diagnostics is a flywheel—the top-of-funnel that activates patients—and why "we have Quest/Labcorp, so we're good" is the exact mindset keeping innovation stuck. He also shares how Molecular Testing Labs attacked the hardest access problem first (HIV/STI), what happened when they removed friction from PrEP care, and why lab-based at-home testing matters because it protects the integrity of the data (not just the experience).

You'll also hear a forward-looking take on self-collection, routine testing for chronic disease + wellness, cost transparency, and where AI could take us next—toward forecasting health like we forecast weather.

What you'll learn:

• Why James calls diagnostics "the flywheel" for activating patients

• The two stats that should change how leaders budget for labs ("70% of clinical decisions" vs "7% of spend" — as James cites)

• Why self-collected, lab-processed testing beats "rapid-only" testing when data/reporting matters

• How at-home testing can reduce stigma and improve public-health surveillance

• What "patient-as-decision-maker" healthcare could look like in the next 5–10 years

If you care about prevention, care gaps, data integrity, and making healthcare actually work for more people—this one's for you.

Chapters

00:00 — Boombostic Health "In the Wild" @ HLTH 2025 (Vegas)
00:45 — Baseball dads, real life, and the cost of ambition
02:05 — "Everyone should have access to diagnostics" (mission)
03:00 — Why the "Diagnostic Zone" is a signal moment
04:30 — The stat gap: labs drive decisions, not spending
05:45 — Why they started with HIV/STI (the hardest use case)
07:30 — Self-collection scale + what it unlocked for access
08:10 — PrEP friction: stigma + testing barriers (and the unlock)
09:45 — The Abbott at-home multiplex test: what's new + why it matters
11:05 — Rapid vs lab: the real issue is data integrity + reporting
12:40 — What's next: routine tests, chronic disease, wellness expansion
16:15 — AI, avatars, and "forecasting health like weather"
18:10 — Bradley's lens: signals, patterns, and getting patients on the right interventions
20:34 — Wrap + why data in will determine everything

#BoombosticHealth #HLTH2025 #Diagnostics #MolecularDiagnostics #LabTesting #PreventiveCare #AtHomeTesting #PublicHealth #CareGaps #HealthcareInnovation #DigitalHealth #AIinHealthcare #PrEP #STITesting

In this episode of Boombostic Health, Bradley Bostic sits down with Nitesh Shroff, CEO and co-founder of Arintra, live from ViVE, to discuss how AI is being used to tackle one of healthcare's most painful and overlooked challenges: revenue cycle management.

Arintra's origin story started with a shocking $19,000 hospital bill caused by a coding error. That experience exposed how fragile, confusing, and expensive healthcare billing can be for patients and providers — and led Nitesh and his co-founder to build an AI-powered approach designed to make healthcare payments more accurate, transparent, and efficient.

Nitesh explains how Arintra uses explainable AI, clinical and financial agents, and human-in-the-loop learning to automate medical coding, prevent denials, support prior authorization, and help health systems get paid accurately and on time. The company's technology works directly inside EHR workflows, including Epic and athenahealth, helping reduce friction for providers while improving trust and adoption.

This conversation goes beyond automation hype. It explores why revenue cycle has become mission-critical for health systems, why denials keep increasing, why the supply of skilled coders cannot keep pace, and why explainability may be the key to making AI work safely in healthcare.

In this episode:
00:00 — Live from ViVE with Nitesh Shroff of Arintra
01:36 — The $19,000 hospital bill that sparked Arintra's mission
04:22 — How explainable AI agents understand clinical and financial context
06:58 — Applying safety-first AI lessons from self-driving cars to healthcare
07:57 — Why documentation, coding, and payment must all align
09:04 — How customer pain points guide Arintra's roadmap
10:07 — The ROI opportunity for health systems
11:23 — Why revenue cycle complexity and denials are accelerating
12:38 — What better billing accuracy means for patients
14:58 — The future of prior authorization, compliance, and payment transparency

Healthcare revenue cycle is often treated as a back-office function. But as Nitesh and Bradley discuss, it is the financial lifeblood of healthcare — and one of the places where AI may create immediate, measurable impact.

Watch the full conversation to hear how Arintra is helping health systems reduce complexity, improve accuracy, and bring more trust into one of healthcare's most broken systems.

Subscribe to Boombostic Health for more conversations with the builders, operators, and leaders transforming the future of healthcare.

 In this episode of Boombostic Health, Bradley Bostic interviews Jeff Fischer, president of Longhorn Vaccines & Diagnostics, at the JPMorgan Healthcare 2025 conference.

They discuss Jeff's unexpected journey into healthcare, the impact of his military background on his leadership style, and the revolutionary sample collection technology developed by his company during the pandemic. The conversation also touches on advancements in vaccine development and innovative approaches to treating sepsis, highlighting the importance of entrepreneurship in healthcare. 

Recorded live at the JPMorgan Healthcare 2025 conference in San Francisco, this episode highlights:

1. Revolutionary Sample Collection Technology: Discover how Longhorn Vaccines & Diagnostics scaled from 30,000 to 25 million units during the pandemic, transforming the handling of infectious samples.
2. Universal Influenza Vaccine Development: Learn about their 15-year journey towards creating a universal vaccine, aiming to prevent future pandemics.
3. Sepsis Treatment Innovations: Explore their groundbreaking work in developing therapeutics to prevent and treat sepsis, potentially impacting inflammatory diseases and more.

Episode Title: Healthcare Innovation with Steve Yaskin - AI Agents, Clinical Data, and the Future of Digital Health

Guest: Steve Yaskin, Founder and Board Member of Health Gorilla

Episode Summary:

In this episode of Boombostic Health, we welcome Steve Yaskin, a visionary healthcare entrepreneur and founder of Health Gorilla. Steve shares insights from his journey in healthcare, starting from his background in theoretical physics to becoming a leader in clinical data exchange. He discusses the evolution of Health Gorilla and its role in the Trusted Exchange Framework Common Agreement (TEFCA), a significant milestone in healthcare data interoperability.

Steve also introduces his latest venture, BeHuman.Health, a startup currently in stealth mode, and shares his excitement about its potential impact on the healthcare industry. The conversation delves into the importance of clinical data, the challenges of data utilization, and the transformative role of AI agents in healthcare workflows. Steve emphasizes the shift towards preventative care and the need for comprehensive, longitudinal patient data to improve health outcomes.

Key Topics:

• Steve Yaskin's journey from theoretical physics to healthcare entrepreneurship

• The founding and growth of Health Gorilla

• The significance of TEFCA in healthcare data exchange

• Introduction to BeHuman.Health and its potential impact

• The role of AI agents in automating healthcare workflows

• The shift towards preventative care and the importance of clinical data

Links:

• BeHuman.Health

• Health Gorilla

Subscribe & Follow:

Stay updated with the latest episodes by subscribing to Boombostic Health on your favorite podcast platform. Follow us on social media for more insights and updates.

Watch on YouTube: https://youtu.be/IQqQDXPgGM8

Key Topics:

• Transition from aerospace innovation to healthcare diagnostics and systems thinking
• The balance between structured processes and innovation in lab operations
• How program management practices from defense are transforming healthcare workflows
• The role of diagnostics in unlocking personalized, data-driven care
• Impact and evolution of home testing post-pandemic
• Bridging consumer health and traditional care with digital health tools
• AI's role in automating workflows and enhancing patient engagement
• The future of diagnostics as the foundational infrastructure of healthcare
• Leadership strategies for agility, innovation, and scaling in healthcare labs
• The importance of early diagnostic engagement for healthy aging

Timestamps:

00:00 - Introduction to Eric Strafel and his transition from aerospace to healthcare diagnostics
02:24 - The importance of systems thinking and process robustness from aerospace in healthcare
03:17 - Impact of program management practices in healthcare labs
04:37 - The role of diagnostics in addressing barriers to testing and care engagement
05:24 - The evolution and future of home testing post-pandemic
07:15 - The integration of consumer-centered health and traditional care through digital tools
07:35 - How AI automates lab workflows and improves capacity
09:06 - The vision of diagnostics as the data engine powering personalized healthcare
10:24 - The critical role of diagnostics in the future of healthcare data ecosystems
11:13 - The importance of early diagnostics for healthy aging
12:11 - Leaders' focus on innovation, agility, and scaling in the diagnostic industry

Resources & Links:

• Molecular Testing Labs
• Eric Strafel LinkedIn

Episode Description:
AI is moving fast in healthcare, but the real question is not who has the newest tool. It is whether the data behind it can be trusted.

In this episode of Boombostic Health, Marcus Gordon sits down with Michael Meucci, CEO of Arcadia, to discuss what it will actually take for AI to improve care delivery, reduce friction, and create measurable impact across the healthcare system.

Michael shares why healthcare organizations need complete, timely, clinically relevant data to make AI useful and safe. He explains how fragmented information can create risk instead of intelligence, why rural healthcare may become one of the most important innovation opportunities in the country, and how leaders need to rethink workflows instead of simply layering AI on top of broken processes.

The conversation also explores the growing role of the healthcare consumer, the pressure facing hospitals and health plans, and why the next 24 months may reshape how care is delivered, measured, and experienced.

Key Takeaways:

1. AI in healthcare is only as strong as the data behind it.
   Michael explains why trusted, complete, timely, and relevant data is essential for AI to support better decisions and avoid creating more noise.

2. Rural healthcare may become a major innovation frontier.
   With new national attention and investment, rural hospitals and critical access facilities have an opportunity to adopt modern care models, virtual-first approaches, and advanced technology in ways that could reshape access.

3. Leaders need to redesign workflows, not just adopt tools.
   Michael challenges healthcare leaders to rethink long-standing assumptions around EHRs, operating models, automation, and how teams use technology to manage patients, panels, and performance.

Topics Covered:
Healthcare AI beyond the hype
Why trusted data matters in clinical decision-making
The risk of incomplete or outdated data
How AI can support providers, patients, health plans, and health systems
The role of longitudinal patient data
Rural healthcare transformation
Health equity and access to care
Leadership in an AI-driven operating environment
Why workflow redesign matters
The future role of the healthcare consumer

Timestamps:
00:00 Introduction: Michael Meucci, CEO of Arcadia
00:16 What it means to lead a healthcare data and AI company today
01:18 Why healthcare needs AI to work amid cyber threats and margin pressure
02:48 Trust, efficacy, and data integrity in healthcare AI
03:28 Why AI models need timely, complete, and transparent data
05:00 The opportunity to expand access in rural communities
05:35 Rural health transformation and the future of critical access hospitals
08:05 Leadership, workflow redesign, and changing how teams think about AI
10:27 Rethinking tools like Salesforce, EHRs, and workflow systems
12:56 What is most exciting about the next 24 months in healthcare
13:29 Rural care, data liberation, and the rise of the healthcare consumer
14:57 Closing thoughts

Guest:
Michael Meucci, CEO of Arcadia

About Boombostic Health:
Boombostic Health features conversations with the leaders, innovators, and builders shaping the future of healthcare. Hosted by Bradley Bostic, the podcast explores the ideas, technologies, and operating models transforming care delivery, diagnostics, data, AI, and patient outcomes.

By the time most people hear "dementia," their brain has been sounding the alarm for years.

In this episode of Boombostic Health, Dr. John Showalter shares his journey from internist to healthcare technology innovator. He explains how AI and digital tools can support early detection and intervention for cognitive decline—before daily life starts to fall apart.

The conversation highlights how lifestyle changes can improve cognitive health, why screening the brain should be as routine as checking blood pressure, and how integrating technology into healthcare systems can scale better outcomes. Real-life success stories show what's possible when you catch problems early and give people a path to act.

Takeaways

• Dr. Showalter's journey from medicine to healthcare technology is inspiring.

• AI can enhance caregiver efficiency and patient care.

• Early detection of cognitive decline is crucial for effective intervention.

• Lifestyle changes can significantly impact cognitive health.

• Integration of technology into healthcare systems is essential for scalability.

• Personalized brain health action plans can improve patient outcomes.

• Social isolation and loss of purpose are key factors in cognitive decline.

• Real-life success stories demonstrate the effectiveness of early intervention.

• Healthcare innovation requires collaboration between technology and clinical expertise.

• The future of cognitive health lies in proactive, lifestyle-based approaches.

Chapters
00:00 Innovating Healthcare: A Journey into Technology
02:39 The Role of AI in Patient Care
05:34 Cognitive Health: Early Detection and Intervention
08:24 Lifestyle Changes and Cognitive Decline
11:07 Integrating Technology into Healthcare Systems
14:08 The Future of Cognitive Health and AI
17:03 Real-Life Success Stories in Cognitive Health

About Dr. Showalter
Dr. John Showalter is an internist and clinical informatics leader who has been obsessed with the data side of care since his first DNA research job at 14. Trained in biomedical engineering and medical informatics, he went on to lead major EHR implementations and build a state-of-the-art analytics center from a $0 to $6.5M budget, earning a Premier 100 IT Leaders award along the way. Today, he focuses on turning complex data and AI into practical tools clinicians actually use, helping detect disease earlier and improve patient outcomes at scale.

Resources

• Linus Health – digital cognitive assessment and brain health platform: https://www.linkedin.com/company/linus-health/posts/?feedView=all

• Connect with Dr. John Showalter on LinkedIn: https://www.linkedin.com/in/johnshowaltermd/

• Boombostic Health podcast – more episodes on AI, diagnostics, and the future of care: https://www.boombostichealth.com/podcast

Tags
healthcare innovation, artificial intelligence, cognitive health, early detection, lifestyle changes, patient care, technology integration, healthcare systems, dementia, health tech

This episode dives into the critical role of real-world evidence and data in transforming healthcare, emphasizing how data privacy, de-identification, and innovative tokenization unlock large-scale insights with minimal risk. Presented by industry veterans, it explores methods to responsibly utilize data for research, clinical trials, and patient care improvements, while addressing common misconceptions and trust issues.

In this episode:

• The importance of real-world data and evidence for healthcare advancement
• How de-identification and tokenization protect patient privacy while enabling large-scale analysis
• The benefits of open source tokenization models versus proprietary solutions
• Practical steps to start using de-identified data for research and clinical decision-making
• The emerging role of AI, wearables, and consumer data in personalized healthcare
• The evolving landscape of data monetization, partnerships, and purpose-driven analytics
• Future of comprehensive data access, trust-building, and patient ownership considerations
• How AI accelerates insights while ensuring data quality and security

Timestamps:

00:00 - Introduction: Healthcare innovation in Indianapolis & the focus on real-world evidence
00:34 - Why healthcare data privacy regulations were designed for protection, not suppression
01:03 - Industry veterans John and Julie on safe data usage and innovation
01:56 - The 18-year journey into real-world data and evidence with HC1
02:38 - How de-identification preserves privacy, scales data, and enables AI-driven insights
03:21 - The role of data in addressing diagnostic gaps and patient journeys
03:53 - The necessity of large-scale, unbiased data for research and healthcare delivery
04:50 - Explaining tokenization simply and why it matters
05:06 - The challenge of integrating data from multiple sources without bias
06:17 - How consumer wearables add depth to patient understanding
07:10 - Therapy development, clinical trials, and the power of de-identified data
07:42 - The significance of bias reduction in healthcare data analytics
08:36 - Path to monetization: Purpose-driven data use versus the race to the bottom
09:00 - The importance of aligning with organizations sharing your mission
09:48 - Clinical trials and real-world evidence improving enrollment and outcomes
10:57 - Strategies for building trust and ensuring patient security in data sharing
11:25 - Practical steps for initiating de-identification & tokenization
12:17 - Privacy-preserving record linkage & open source tokenization solutions
13:20 - The significance of rigorous de-identification processes and certification
14:13 - How tokenization connects disparate datasets without compromising identity
15:11 - Open source solutions versus commercial fee-based tokenization providers
16:45 - The importance of responsible data sharing and avoiding exploitative marketplaces
17:41 - Enhancing clinical trials with real-world evidence and reducing risks
20:13 - The impact of regulatory changes and partnerships in trials
21:06 - Enabling precision medicine through aggregated, de-identified data
22:22 - The role of CROs and third-party organizations in trial success
23:20 - Using advanced AI for device tracking, supply chain, and supply chain data
24:18 - Challenges and opportunities with physician notes and unstructured data
25:41 - The ongoing need for AI refinement and risk management in de-identification
27:02 - Addressing the potential consequences of data breaches and errors
28:41 - The technical feasibility and limitations of perfect de-identification
29:46 - Handling physician notes, abbreviations, and unstructured data responsibly
31:07 - The future of diagnostics, genomics, and embedded AI in healthcare standardization
32:07 - How tokenized, integrated data empowers providers and payers
33:13 - The importance of clean, trusted data for AI accuracy
34:24 - Personalized, real-time insights improving patient care and provider decision-making
36:47 - The untapped potential of lab and rare disease data for proactive care
38:49 - The challenge of small data scale in specialty labs and opportunities for collaboration
40:37 - Using de-identified lab data to predict disease progression and improve outcomes
43:13 - Integrating consumer wearable and biometric data into healthcare insights
44:14 - The power of personal health data for early detection and prevention
45:24 - Expanding access to EHR data and overcoming legislative barriers
47:11 - Building a culture of data ownership and creating trust with patients
48:32 - The potential influence of patient incentives, transparency, and societal changes
50:09 - Closing thoughts: Trust, purpose, and technology shaping the future of healthcare data

Nick's unconventional journey—from computer science to law to healthcare—offers a unique lens on these pressing issues. His technical expertise, coupled with a legal and ethical approach, underscores the importance of transparency and responsibility in implementing AI. "AI in healthcare isn't just a technology—it's a trust mechanism," Nick emphasizes. "Transparency in how AI systems are built and maintained is non-negotiable, especially when they influence life-altering decisions."

The regulatory landscape for AI is still taking shape, but some frameworks, like the European Union's AI Act, are emerging as global benchmarks. The EU AI Act categorizes AI systems by risk, imposing stricter requirements on those deemed "high-risk," such as healthcare applications. Nick predicts this model will influence policies worldwide. "Much like the GDPR transformed privacy laws globally, the EU AI Act is setting the foundation for how AI is governed across industries," he explains.

The conversation around AI in healthcare isn't just about rules—it's also about ethics and practical implementation. AI's dynamic nature makes it challenging to regulate, as it evolves based on data inputs and usage patterns. Nick argues that transparency and robust monitoring mechanisms will be key. "AI must be designed with accountability baked in. It's not about preventing issues entirely but about having systems in place to identify and resolve them quickly when they arise."

Cybersecurity is another critical area where healthcare must advance rapidly. The industry's reliance on interconnected systems and vast amounts of sensitive data makes it an attractive target for cyberattacks. The consequences of a breach go beyond financial losses—patient safety and trust are on the line.

The ransomware attack on a prominent healthcare billing company is a stark reminder of these vulnerabilities. The attack disrupted cash flow for nearly 91% of U.S. healthcare providers, forcing some to take drastic measures to keep their doors open. "Continuity planning isn't just a good practice—it's a necessity," Nick says. "Healthcare providers must rethink their reliance on single points of failure, especially in critical areas like billing and patient data management."

Practical steps include developing contingency plans, conducting regular "tabletop exercises" to simulate potential breaches, and diversifying vendor relationships. "Organizations need to treat cybersecurity with the same seriousness they apply to patient care," Nick advises. "If your systems go down, your ability to provide care is compromised—that's unacceptable in a field where lives are at stake."

Despite these challenges, both Nick and Bradley remain optimistic about the future of healthcare. They view AI as an enabler rather than a disruptor. "AI won't replace people—it will empower them," Nick asserts. "It's about using technology to enhance human capabilities, not diminish them." Bradley shares this perspective, emphasizing that AI's ultimate promise lies in its ability to make healthcare more personalized, efficient, and equitable.

From the outside, it looks simple: order → kit arrives → collect → mail back.
Behind the scenes, scaling that experience requires automation, reliability, and speed.

In this conversation, Jeff Shattuck explains how DOT Corp uses automation, robotics, and AI to reduce the time from order to shipment, expanding what's possible for home diagnostics and precision medicine.

Key moments

• DotCorp transitioned from printing to healthcare logistics.
• AI and robotics are streamlining healthcare processes.
• At-home testing is becoming more prevalent post-COVID.
• Less invasive testing methods are emerging.
• Precision medicine will rely on at-home diagnostics.
• Accountable care programs are driving demand for home testing.
• Collaboration with major labs enhances service delivery.
• The healthcare landscape is rapidly evolving.
• Patient empowerment is key in modern healthcare.
• Future innovations will focus on accessibility and efficiency.

Chapters

00:00 The Entrepreneurial Journey of DotCorp
05:19 Transforming Diagnostics: Home Testing Revolution
07:46 The Future of Precision Medicine and Home Testing

Connect

Jeff Shattuck: https://www.linkedin.com/in/jeffoshattuck/

Bradley Bostic: https://linktr.ee/BradleyBostic

Boombostic Health: https://www.boombostichealth.com/

For those unfamiliar, regenerative medicine emphasizes the body's ability to heal itself. This includes therapies like peptides, stem cells, and treatments aimed at restoring function without invasive procedures. Chris notes a profound shift: many seasoned surgeons and anesthesiologists are pivoting to regenerative practices, recognizing that the high-stakes environment of Western medicine often comes with shrinking margins and intense liability. "I've seen seasoned professionals turn to regenerative medicine, not just for the income streams but for a fresh, proactive approach to healthcare," Chris explains. In his experience, the shift isn't merely financial—it's philosophical.

Chris's own story highlights the personal side of regenerative medicine. Following a sports injury, he found himself exploring alternative paths to healing—ones that didn't rely on the typical pharmaceutical or surgical interventions. "I needed to find a way to stay active without compromising my body's longevity," he says. His exploration of regenerative techniques has become a lifestyle, encompassing everything from stem cell therapies to cutting-edge physical regimens like hot yoga. This journey has enabled him to help others, particularly former athletes, to find sustainable health solutions that extend far beyond the sports field.

Beyond the physical, Chris also touches on the mental resilience that regenerative medicine brings. He describes the phenomenon where many patients, himself included, find renewed energy and clarity. This aligns well with studies showing that proactive health measures not only improve physical wellness but mental acuity. For Bradley, this isn't just an emerging trend—it's a philosophical shift. He adds that individuals willing to adopt preventative, health-focused habits are often better equipped to handle life's pressures, both personally and professionally.

This type of medicine, however, isn't accessible to all. Regenerative treatments are largely cash-based, putting them out of reach for many. Yet, Chris argues that the value they bring, in terms of reduced downtime and improved quality of life, is unparalleled. "If you're considering regenerative options, start by consulting with a trusted physician," he advises, emphasizing that expertise is paramount in this field, where unqualified practitioners can often get it wrong.

Bradley and Chris's discussion is a powerful reminder that innovation isn't just about technology; it's about rethinking our entire approach to health. Whether it's an athlete like Chris seeking to extend his mobility or a surgeon reconsidering their career path, regenerative medicine holds transformative potential. In this dialogue, Bradley and Chris make one thing clear: the future of healthcare will be driven not only by medical advancements but by an ethos that prioritizes sustainable health, financial literacy, and a proactive approach to life.

In this episode of Boombostic Health, Bradley Bostic leads a timely conversation with healthcare and diagnostics leaders on how real-world patient data, genomics, AI, and embedded research models are changing the way healthcare systems identify risk, close care gaps, and deliver more personalized care.

The discussion moves beyond the promise of innovation and into the practical realities of adoption. How do we turn routine care into continuous learning? How do we prove the value of advanced diagnostics to payers? How do we expand access without creating new forms of bias? And how do we help patients and providers trust the data, the science, and the recommendations that follow?

From home-based testing and consumer-driven care to reimbursement, incidental findings, data diversity, and health economics, this episode explores what it will take to move diagnostics from the edge of healthcare innovation into the center of everyday clinical decision-making.

What You'll Learn

• How diagnostics are shifting from episodic testing to continuous healthcare intelligence
• Why real-world data is essential to predicting outcomes and improving care pathways
• How genomics and AI can support more personalized, proactive care
• What it takes to build the business case for diagnostic innovation
• Why reimbursement models must evolve to keep pace with scientific progress
• How embedded research can make routine care more evidence-driven
• Why patient trust, education, and transparency are critical to adoption
• How data diversity can help reduce bias and improve care for underserved populations

Why This Conversation Matters

Healthcare does not have a data shortage. It has an actionability problem.

The future of diagnostics will depend on the ability to connect data to decisions, research to routine care, and innovation to measurable impact. This conversation makes the case for diagnostics as a strategic foundation for better care, smarter economics, and more equitable outcomes.

Key Moments

00:00 — Why diagnostics are becoming central to healthcare innovation
02:38 — Embedding research into routine care
04:17 — Using data to predict health outcomes
06:10 — Making the case for payer coverage and cost savings
09:58 — Bringing diagnostic models into clinical workflows
11:14 — The rise of home-based and consumer-driven testing
14:23 — Managing incidental findings responsibly
17:34 — Connecting diagnostics to health economics
24:07 — Addressing disparities, access, and data bias
27:33 — Moving from research to routine clinical care
32:39 — Empowering patients through health technology

Featured Topics

Real-world evidence
Personalized medicine
Genomics and AI
Diagnostic innovation
At-home testing
Reimbursement and payer coverage
Health economics
Data diversity and bias
Patient engagement
Clinical workflow integration

Resources

hc1 
uMed 
Simple HealthKit

Closing Thought

The next era of healthcare will not be defined by more testing alone. It will be defined by whether diagnostics can help turn real-world data into earlier action, better decisions, and measurable improvements in care.

Bradley's inspiration began early, influenced by his father, a banker with a knack for evaluating risk. Conversations with his dad laid the foundation for Bradley's entrepreneurial mindset. "Everyone has ideas," Bradley shared, "but unless you bring the right elements together, you aren't going to succeed." This principle became his north star, guiding him through ventures ranging from e-commerce to healthcare innovation.

His pivot into healthcare was deeply personal. After losing his mother to colon cancer, Bradley saw firsthand the disjointed and reactive nature of the healthcare system. "She was otherwise healthy, but she never had a colonoscopy recommended," he recounted. This experience ignited a passion for proactive, patient-centric care, leading him to focus on integrating data to enhance diagnostics and treatment.

Bradley's vision culminated in hc1, a company leveraging lab data to personalize care. He recognized that laboratory results hold unparalleled potential in healthcare, describing them as "the most powerful dataset across all of healthcare." By unlocking insights from these results, hc1 ensures patients receive the right tests and treatments at the right time, ultimately saving lives and reducing costs.

However, his journey wasn't without challenges. Bradley recalls a conversation with a healthcare CFO who questioned the revenue impact of a system designed to reduce hospital visits. "It was shocking," Bradley admitted, "but it reinforced the need to align innovation with the economic realities of healthcare." This realization became the cornerstone of his approach: marrying transformative ideas with sustainable business models.

His work aligns with the industry's shift toward value-based care, where providers are rewarded for keeping patients healthy rather than for the volume of services rendered. Bradley sees this as a turning point: "It's creating the right kind of alignment between payers and providers, focusing on outcomes instead of events."

Bradley's optimism about the future of healthcare is infectious. He credits advancements in cloud computing and artificial intelligence as enablers of what he calls a "golden era" in medicine. Yet, he remains grounded, emphasizing the importance of community and mentorship. "Every day, I wake up with a day-one mentality," he said. "I want to help others achieve their goals faster by sharing what I've learned."

As Bradley continues to lead hc1 and its sister companies, his focus remains clear: creating solutions that are as impactful as they are sustainable. His dedication to innovation, coupled with a deep respect for the human side of healthcare, serves as an inspiration for anyone looking to make a difference in this complex industry.

In Bradley's words, "If we align technology, economics, and patient care, we can create a future where everyone benefits. That's not just an aspiration—it's a responsibility."

Recorded live at ViVE, Bradley Bostic sits down with Aneesh Chopra, the first Chief Technology Officer of the United States, entrepreneur, and former Obama administration tech leader who helped open up Medicare data to the public.

This conversation explores what happens when government transparency, private-sector innovation, and AI collide.

Aneesh shares:

• Why "open data" in healthcare became the default and why it was always bipartisan

• How his company CareJourney turned Medicare data into physician performance intelligence and why it mattered

• What "outcomes as a service" could mean for the next era of payment reform

• A real-world example of AI voice agents helping a medical center jump from 2 to 4 Stars in 90 days

• Why actuarial math alone won't scale value based care

• The concept of a "health information fiduciary" aligned with patients, not billing codes

• How AI front ends could deliver high-touch engagement to every patient, not just the highest risk 10 to 15 percent

Aneesh makes a bold claim:

We constrain care today because it is labor intensive.

But if AI agents can deliver hundreds of touchpoints per week, escalate when necessary, and guide patients along protocol driven pathways, value based care becomes abundant and scalable at a fraction of the cost.

He is not talking about theory. He is already using conversational AI to securely summarize his own medical record and labs.

The infrastructure is here. The data is open. The agents are live.

The only question is whether we will align incentives fast enough to let this scale.

In this episode of Boom Bostic Health, host Bradley Bostic interviews James Maskell, a thought leader in functional medicine and health economics. They discuss Maskell's journey into the field, the challenges of conventional medicine, and the potential for reversing chronic diseases through lifestyle changes. The conversation also touches on the importance of community in health, the shift towards value-based care, and the future of cognitive health in the context of functional medicine.

Watch full episode on YouTube

Takeaways

• James Maskell's early exposure to alternative medicine shaped his career.
• The medical system is not designed for chronic disease management.
• Chronic diseases can be reversible with lifestyle changes.
• Patient empowerment is crucial in reversing chronic illnesses.
• Functional medicine focuses on the root causes of health issues.
• Community support enhances health outcomes.
• Value-based care incentivizes keeping patients healthy.
• Loneliness is a significant factor in health outcomes.
• Cognitive health can be improved with precision medicine.
• Collaboration between conventional and functional medicine is essential.

Chapters

00:00 Introduction to Functional Medicine and Longevity
02:39 James Maskell's Journey into Health Economics
05:42 Reversing Chronic Disease: A New Approach
08:23 The Evolution of Medicine and Entrepreneurial Ventures
11:06 Challenges in Conventional Medicine
13:51 Value-Based Care and Its Implications
16:43 The Role of Community in Health
19:32 Future of Cognitive Health and Functional Medicine

To learn more about James Maskell, visit his website here.

The business of healthcare is broken — but intelligence might finally fix it.

In this episode of Boombostic Health, Bradley Bostic and Jason Wenell reveal how to build an AI-ready healthcare system that learns, adapts, and delivers real value. Jason shares his three-layer framework — upskill people, automate workflows, and build AI-native systems that think.

Discover how AI is becoming the engine behind value-based care and what it means for the future of healthcare innovation.

Takeaways

• AI is revolutionizing healthcare and other industries.
• Value-based care relies heavily on data and predictive analytics.
• AI can help identify social determinants of health.
• Upskilling healthcare professionals is crucial for AI integration.
• AI native applications will define the future of healthcare technology.
• Data is considered the new oil in the healthcare sector.
• Personalized healthcare will improve patient outcomes significantly.
• AI should enhance human capabilities, not replace them. 
• Ethical considerations in AI development are paramount.
• The future of healthcare is promising with the right AI applications.

Chapters

00:00 Introduction to AI in Healthcare
03:13 AI Applications in Value-Based Care
06:04 Navigating Change Management in Healthcare
09:00 The Shift to AI Native Applications
11:49 Data as the New Oil in Healthcare
15:00 Personalized Healthcare Through AI
18:05 Transitioning to AI Native Solutions
20:59 Ethical Considerations in AI Development
24:05 The Future of Human-Centric Healthcare

www.boombostichealth.com

https://linktr.ee/BradleyBostic

www.hc1.com

www.linkedin.com/in/bradleybostic 

#boombostichealth #aihealthcare #healthcare #digitalhealth #healthcareinnovation #healthtech #valuebasedcare #ai

In this episode of Boombostic Health, Bradley Bostic interviews Dustin Suntheimer, Director of Commercial Operations in diagnostics, to discuss the advancements in oncology testing and the impact of genetic profiling on cancer treatment.

They explore the evolution of cancer diagnostics, the significance of omics, and the role of advanced genetic testing in personalizing treatment plans. The conversation also touches on the accessibility of these tests across different demographics and the future of cancer care, emphasizing the importance of collaboration between healthcare providers and laboratories.

Watch full episode on YouTube here

Takeaways

• The state of oncology testing has significantly improved over the years.
• Advanced molecular assays can lead to better patient outcomes.
• Digital pathology allows for remote examination of tissue samples.
• Genetic testing can help eliminate ineffective treatments.
• Molecular profiling is essential for personalized cancer therapy.
• Omics encompasses various fields that enhance our understanding of biology.
• Precision medicine tailors treatment based on individual genetic profiles.
• Genetic testing should be accessible to all patients, regardless of socioeconomic status.
• Healthcare providers must be aware of genetic testing guidelines.
• Collaboration between physicians and laboratories is crucial for patient care.

Chapters

00:00 Introduction to Oncology Testing and Its Evolution
03:01 Understanding Anatomic Pathology and Molecular Testing
06:00 The Importance of Genetic Profiling in Cancer Treatment
08:55 The Role of Omics in Cancer Diagnostics
11:52 Advanced Technologies in Cancer Testing
14:54 The Impact of Genetic Testing on Preventative Care
17:49 Tracking Cancer Recurrence with Advanced Testing
21:00 The Importance of Family History in Cancer Risk
24:05 Guidelines for Genetic Testing and Preventative Measures
26:55 Healthcare Innovation and the Future of Cancer Treatment
29:55 The Socioeconomic Factors in Accessing Genetic Testing
33:08 Conclusion and Future Directions in Oncology

We've been "empowering patients" for a long time in theory. AI is the first thing that's made it feel real at scale. But Amy makes a key point: if AI doesn't have the right data under it, it's basically just a faster version of "Dr. Google."

This episode gets into interoperability, why standards still matter, what privacy and consent should look like in plain English, and how patients could use AI to navigate care anytime—like a Saturday night when you're not sure if something is urgent.

Amy also shares a personal story about her daughter using AI to review old records, spot a misclassification, and reopen a path into a clinical trial. It's a great reminder: the future isn't just chatbots. It's access + context + trust.

• Why AI is finally making patient empowerment real
• The "Dr. Google" problem (and how to get past it)
• Why interoperability is the foundation for personalized AI
• Why standards like FHIR still matter
• What "clear consent" should look like for patients
• How AI can surface insights buried in years of medical history
• What healthcare could look like when patients can get help anytime 

Nigel has taken companies from napkin sketch to multi-billion-dollar scale — most notably co-founding Lumeris and now leading Diagnostic Robotics. He shares what it really takes to scale in healthcare, why execution matters more than ideas, and how AI is transforming the 80/20 rule: shifting clinicians' time from endless paperwork back to patient care.

Together, they unpack:

• Why AI in healthcare isn't about replacing doctors — it's about unlocking billion-dollar impact.
• How Nigel scaled Lumeris into a multi-billion-dollar company and the lessons he carried forward. 
• The role of agentic AI in automating administrative tasks and enabling faster, cheaper, and higher-quality care.
• Why the next wave of healthcare innovation will be built by operators who understand both incentives and execution.
• The untold story of scaling companies in a $4T industry under massive pressure to change.

Chapters

00:00 Introduction to Diagnostic Robotics and Nigel's Journey

08:37 The Drive Behind Innovation in Healthcare

16:56 Understanding Agentic AI in Healthcare

25:31 AI in Healthcare: Streamlining Administrative Tasks

29:00 Transforming Patient Engagement and Care Quality

30:51 Lessons from John Doar: Execution and Preparation

36:50 The Role of Technology in Healthcare

46:13 Innovation Under Pressure: Opportunities in Healthcare

In this must-listen episode of Boombostic Health, Bradley Bostic is joined by healthcare innovation experts Jeff Myers and Matt Martocci to uncover the untapped potential of healthcare labs. Together, they discuss how labs are evolving from overlooked assets to strategic powerhouses driving better patient outcomes, operational efficiency, and groundbreaking preventative care.

What You'll Discover:

• The rise and fall of offsite core labs: Why history is repeating itself and what it means for the future of healthcare systems.

• The battle for lab dominance: Hospitals vs. physician-owned group practices—who's winning and why?

• How wearable tech, AI, and advanced diagnostics are reshaping the healthcare landscape.

• The economic and strategic value of labs: Why health systems are rethinking their approach to lab operations.

Key Highlights:

• Jeff Myers explains the economics behind lab consolidation and how health systems can maximize their lab assets.

• Matt Martocci dives into the competitive rise of physician-owned group practices and their impact on hospital labs.

• Bradley Bostic shares insights into the future of diagnostics, including the role of AI, biometric sensors, and preventative lab testing in improving longevity.

Why It Matters:

Labs are no longer just a back-office function—they're the hidden Rembrandts in the attic of healthcare systems. With 75-80% of medical records tied to lab data, the opportunity to leverage this information for predictive and preventative care is massive. This episode explores how labs can transform healthcare delivery and why they're critical to the future of patient care.

Don't Miss:

• A fascinating discussion on how lab data could help predict diseases like Alzheimer's decades before diagnosis.

• The role of wearable devices like WHOOP and Apple Watch in integrating lab insights into everyday health monitoring.

• The bold predictions for the next 10 years of lab innovation—will we see a complete paradigm shift in diagnostics?

In this episode of Boombostic Health, Bradley Bostic interviews Val Adia, CEO of BocaBiolistics, discussing his journey in the healthcare industry, the importance of biobanks in accelerating research, and the future of personalized medicine.

Val shares insights on the role of genomics, the transition from large enterprises to startups, and the unique global capabilities of BocaBiolistics. The conversation emphasizes the need for a preventative approach in healthcare and the potential for improved patient outcomes through innovative technologies.

Watch full episode on YouTube

Takeaways

• Val Adia's journey in healthcare began at the New York Blood Center.
• BocaBiolystics focuses on accelerating research for new therapeutics.
• The company has a global scope in specimen collection.
• Personalized medicine is becoming increasingly important in treatment efficacy.
• The pandemic highlighted weaknesses in healthcare delivery.
• BocaBiolistics supports both diagnostic and pharmaceutical research.
• AI and technology are crucial for analyzing patient data.
• The future of healthcare is moving towards preventative measures.
• Val's passion for oncology drives BocaBiolistics' mission.

Chapters

00:00 Introduction to BocaBiolystics and Val's Journey
02:57 The Role of Biobanks in Accelerating Research
05:50 Personalized Medicine and Genomics
08:47 Transitioning from Large Enterprises to Startups
12:04 The Future of Healthcare and Technology
15:02 Global Scope and Unique Capabilities of BocaBiolystics
19:04 Vision for the Future of BocaBiolystics and Personalized Medicine

In this episode of Boombostic Health, Bradley Bostic and Brent Bolton discuss the transformative potential of agentic AI in healthcare, particularly in improving supply chain efficiency. They explore the tactical nature of healthcare supply chains, the impact of AI on forecasting and inventory management, and the importance of leveraging data for better decision-making.

The conversation also highlights the significant cost savings achieved through effective supply chain management and the collaborative opportunities that arise from partnerships between healthcare systems and suppliers. As they conclude, they reflect on the future of healthcare supply chains and the role of technology in driving improvements.

Takeaways

• Agentic AI holds great promise for healthcare efficiency.
• Healthcare supply chains are often managed in a tactical manner.
• AI can significantly enhance supply chain operations.
• The pandemic highlighted the fragility of supply chains.
• 3D printing may revolutionize healthcare supply logistics.
• Data is crucial for effective supply chain management.
• Benchmarking against industry standards is essential.
• Over $100 million has been saved through improved supply chain practices.
• Collaborative negotiations can benefit both healthcare systems and suppliers.
• AI will play a key role in streamlining procurement processes.

Chapters

00:00 Introduction to Agentic AI in Healthcare
04:33 The Role of Supply Chain in Healthcare
10:45 Impact of AI on Supply Chain Efficiency
16:13 Leveraging Data for Better Supply Chain Management
20:02 Cost Savings and Collaborative Opportunities in Healthcare
24:00 Conclusion and Future of Healthcare Supply Chain

Bradley Bostic sits down with Matthew Holt (The Health Care Blog) for a blunt diagnosis of what's broken in U.S. healthcare and a concrete, numbers-driven proposal to fix it. Holt doesn't just complain. He names incentives, calls out the money flows, and lays out a primary-care "voucher" model designed to cut downstream costs while making primary care a top-tier, high-status job again.

If your organization is still treating primary care like a loss leader and "leakage" like a KPI, this one will sting (in the right way).

Timestamps

00:00 – 01:20 HLTH 2025 setup + dark humor about "keeping subscribers alive"

01:20 – 05:30 Holt's blunt system diagnosis + "nonprofit" and executive pay critique (UPMC example)

05:30 – 08:45 Primary care access crisis + why the ER becomes the default front door

08:45 – 10:50 "Leakage" + the referral-engine reality inside employed primary care

10:50 – 13:15 The concierge-for-all voucher model (the simple math)

13:15 – 16:30 Bradley connects it to value-based care + incentive shifts

16:30 – 18:10 Wrap: fewer complaints, more solutions + where to follow Holt

What you'll hear

Why the U.S. system is expensive by design — and why consumers carry the anxiety.

The uncomfortable truth about "nonprofit" health systems, executive comp, and transparency.

How primary care got turned into a referral engine for high-margin services. 

Holt's two-step path to reform, including a "concierge-for-all" model with simple math behind it.

Where this intersects with value-based care… and where today's versions still fall short.

To learn more about The Healthcare Blog, visit here: https://thehealthcareblog.com/blog/category/health-tech/matthew-holt/

The conversation highlights the need for a shift in healthcare models to better support aging populations and the potential for preventive measures in cognitive health.

Watch full episode on YouTube here.

Takeaways

 - Cognitive decline is a multifaceted issue influenced by environmental factors.
 - Mold exposure can significantly impact cognitive health.
 - Precision medicine offers a promising approach to reversing cognitive decline.
 - TruNeura aims to integrate a multimodal approach to brain health.
 - Holistic health programs can benefit seniors in living facilities.
 - The healthcare system is slowly recognizing the importance of functional medicine.
 - There is a growing demand for personalized cognitive health solutions.
 - Understanding the prodromal period is crucial for early intervention.
 - Community support plays a vital role in managing cognitive health.
 - Preventive measures can start as early as age 30.

Chapters

00:00 Introduction to Cognitive Decline Solutions
02:54 Personal Journey and Mold's Impact on Cognitive Health
06:39 Understanding Environmental Determinants of Health
09:27 The Role of Precision Medicine in Cognitive Health
13:09 Developing a Software Solution for Cognitive Care
15:32 Integrating Cognitive Health in Senior Living
18:00 Holistic Health Approach to Cognitive Decline
21:00 Challenges in Implementing New Health Models
23:49 The Future of Cognitive Health and Prevention

In this episode of Boombostic Health, Marcus Gordon sits down with Dr. Luke Hansen of Arcadia at HIMSS to discuss where AI is beginning to create real value in healthcare. They explore how AI can help expand access, support care teams, surface more meaningful patient context, and identify rising risk earlier.

This conversation goes beyond the usual hype. Dr. Hansen explains the difference between tools that improve efficiency, like summarization and documentation support, and the more meaningful long-term shift toward predictive and agentic capabilities that could reshape care delivery.

For healthcare leaders, operators, and innovators trying to separate real operational value from noise, this is a thoughtful conversation worth watching.

In this episode:

• Why healthcare AI is becoming more practical
• How AI can help expand access to care
• The shift from summarization to predictive and agentic tools
• Why trust and safeguards matter more than hype
• What healthcare leaders should watch as adoption evolves

Guest: Melissa Butterworth, CEO of Advanced Strategic Partners

Overview: Hospitals are under extreme financial pressure—but what if the answer to their budget woes is sitting right inside their own labs? 

In this eye-opening episode, Melissa Butterworth—who's led over $2.4 billion in lab transactions—joins Bradley to explore the growing trend of health systems divesting lab assets. Together, they unpack:

• Why hospitals are selling even profitable lab outreach operations
• How to accurately assess the real value of a lab business
• What happens post-sale—and how to unlock even more value with AI-powered lab insights.

Chapters: 

04:30 Melissa's story: from LabCorp exec to M&A powerhouse

07:20 Why lab outreach programs are being sold off—even with 40%+ margins

10:50 "Compressed value": What hospital labs are really worth to buyers like LabCorp or Quest

15:40 The rise of AI in lab-driven personalized medicine

17:45 Predicting Alzheimer's from routine labs? It's already happening.

17:55 The Role of Labs in Future Healthcare

Key Quote: 

"It's just as hard to play small as it is to play big. So why not go big?" – Bradley Bostic

In this episode of Boombostic Health, Bradley Bostic sits down with Adam McMullin, CEO of AvaSure, to discuss how AI-enabled virtual care is helping health systems improve patient safety, support nurses, and extend clinical capacity without losing the human touch.

AvaSure pioneered virtual safety and is now helping hospitals move beyond pilots into scalable, ROI-driven care transformation. Adam shares how intelligent room technology, computer vision, virtual nursing, and open platform integrations are changing what care teams can see, how quickly they can act, and where scarce clinical resources can be used most effectively.

The conversation gets into the real pressures facing health systems today: patient falls, ED boarding, documentation burden, specialty access, workforce shortages, and the rising issue of violence against care teams.

This is not a conversation about AI replacing clinicians.

It is about using AI and virtual care infrastructure to give clinicians better visibility, better support, and more time with patients.

Key Topics

Virtual safety and the future of patient observation

How intelligent rooms can reduce risk and improve workflow

Why hard-dollar ROI matters for scaling healthcare technology

The role of AI, computer vision, and virtual nursing in care delivery

How AvaSure is helping health systems bring more human connection back into care

Key Takeaway

The future of hospital innovation is not more disconnected technology. It is intelligent infrastructure that helps care teams act sooner, work smarter, and care better.

Healthcare doesn't have a clinical excellence problem.

It has an operations problem.

In this episode of Boombostic Health, Bradley Bostic sits down with Dr. David Atashroo of Qventus to unpack the hidden layer of healthcare that determines whether care actually works: care operations.

The United States leads the world in clinical innovation, yet patients still experience delays, canceled procedures, repeated paperwork, and fragmented care.

Why?

Because the real breakdown in healthcare happens outside the exam room — in scheduling, care coordination, surgical preparation, discharge planning, and the countless operational tasks that surround clinical care.

Dr. Atashroo explains how AI is beginning to transform that operational layer by proactively identifying care gaps, coordinating workflows across the care continuum, and ensuring patients get the right care at the right time.

Instead of adding more dashboards or tools, AI can become the system that orchestrates care itself.

If healthcare is going to improve outcomes, reduce costs, and restore clinician capacity, the next frontier isn't better clinical tools.

It's fixing the operations of healthcare.

In this episode

• Why healthcare's biggest failures are operational, not clinical
• How AI can coordinate care across the entire patient journey
• Why value-based care struggles to execute in real health systems
• How AI can proactively close care gaps and identify risk
• The future of AI as the operating layer of healthcare

Key insight

"If you can make the right thing to do the easy thing to do, you advance value-based care."

Dr. Jay Anders makes that point in his Boombostic Health conversation with Marcus Gordon. He calls for more clinical input into what these systems do and which problems they solve.

We should be asking clinicians where work breaks down, what information they need, and what would give them more time with patients. Their answers should shape the product and how we measure its value.

But how much say do clinicians actually have?

Are they involved early enough to influence what gets built, or brought in after the major decisions have been made?

I'd like to hear from clinicians and the teams building these tools: When does clinical input enter your process, and what has changed because of it?

Watch Jay's perspective here: [YouTube episode link]

#HealthcareInnovation #BoombosticHealth

In this episode of Boombostic Health, Bradley Bostic sits down with Lee Shapiro—Managing Partner at 7wire Ventures, former President of Allscripts, and co-founder of Livongo—to talk about his journey from "recovering lawyer" to building one of the most successful companies in digital health.

Lee shares how he and Glenn Tullman grew Livongo into a public company and ultimately merged with Teladoc in a landmark $18.5 billion deal. He breaks down why healthcare innovation is never an overnight success, how to spot "Uber moments" in healthtech, and why solving consumer hassles is the future of care.

Whether you're an entrepreneur, investor, or operator, this conversation offers a masterclass on building meaningful healthcare businesses that last.

Key Moments

00:00 – Intro: Bradley Bostic welcomes Lee Shapiro of 7wire Ventures

01:40 – From lawyer to entrepreneur: Why Lee left law to build companies

05:20 – Allscripts and the early days of digital health

10:30 – The Livongo story: 6-year grind to IPO and $18.5B Teladoc merger 

13:50 – The B2B2C model in healthcare explained

15:20 – Consumer hassle mapping: Finding healthcare's "Uber moments"

17:20 – Value-based care & empowering the patient

19:40 – Scaling through M&A: The $620M Accolade–Transcarent deal 

25:30 – How 7wire Ventures supports portfolio founders beyond capital

29:20 – Doing well by doing good: Investing with purpose in healthcare

31:10 – Cubs or Sox? Lee's Chicago roots and final thoughts

Key Topics

• Digital health entrepreneurship
• Venture capital in healthcare 
• How Livongo scaled to an $18.5B deal with Teladoc 
• The future of value-based care 
• Consumer hassle mapping and patient empowerment
• Healthcare M&A and scaling strategies

What you'll learn:

• Why 53% of medications don't work as intended

• How social support increases patient survival by up to 50%

• Where healthcare investment is missing the mark

• What the Alice Walton School of Medicine is doing differently

• How AI is closing critical care gaps from anemia to cancer

Chapters

00:00 Introduction to Value-Based Care and AI
04:57 The Journey to Personalized Healthcare
11:12 AI's Role in Transforming Healthcare
18:25 The Importance of Preventive Medicine
25:49 Innovations in Medical Education
33:58 The Future of Healthcare and AI

Watch on YouTube

• Introduction to Lab Stewardship:
• Definition and significance in ensuring optimal patient testing.
• The role of lab stewardship in preventing illness and eliminating wasteful testing.

• Chris's Journey:
• Personal motivations and career path in healthcare.
• The impact of family experiences on his professional focus.

• PDX Tool and Innovations:
• Overview of the PDX tool and its recent updates with 72 new rules.
• The importance of data-driven decisions in healthcare.
• Development of new dashboards like Test Pending at Discharge.

• Balancing Clinical and Financial Goals:
• Strategies for aligning patient care with financial objectives.
• Discussion on multiplex molecular testing and its economic implications.

• Future of Lab Stewardship:
• Transitioning from sick care to well care.
• The potential of predictive analytics and AI in healthcare.
• Addressing chronic diseases through early intervention and data trends.

• Visit the hc1 website

• Healthcare Entrepreneurs: Tips on attracting investors and navigating healthcare tech complexities.
• Investors & Venture Capitalists: Insights into successful investors who engage beyond spreadsheets.
• Anyone Interested in Healthcare Innovation: Discover future trends like AI and remote patient care.

• Investor Insights: Discussion on what makes a great investor in healthcare.
• No Assholes Policy: Importance of choosing the right investors and partners.
• Exploring investors: Their questions, mindset, and suitability for healthcare innovators.

• Curiosity and Listening: Investors who understand and engage with the business.
• Value Creation: Beyond capital, investors should facilitate growth and innovation.
• Avoiding Spreadsheet Buyers: Importance of human and qualitative aspects in investment.

• AI and Data: Emphasis on data-driven strategies and AI's role in healthcare.
• Remote Healthcare: Growth in telemedicine and remote patient management.
• Government Scrutiny: Increased audits and investigations in the provider space.

• Healthcare Entrepreneurs: Tips on attracting the right investors.
• Investors & Venture Capitalists: Insights into successful investment strategies.
• Healthcare Innovation Enthusiasts: Future trends shaping the industry.

Takeaways

• The business of healthcare is fundamentally broken.
• Shadowbox offers an innovative solution for lab test ordering.
• Faxes are still prevalent in healthcare communications.
• Shadowbox has achieved a 20% reduction in denials for labs.
• The Shadowbox system can be applied to various diagnostics, not just labs.
• There is a significant opportunity to flag patients for clinical trials.
• Healthcare interoperability is a $950 billion problem.
• No single solution fits all healthcare interoperability needs.
• The time for healthcare innovation is now.
• Partnerships can enhance healthcare delivery and patient outcomes.

Chapters

00:00 Introduction to Electronic Health Records and Their Challenges

04:52 Innovative Solutions for Lab Test Ordering 

09:05 Expanding Beyond Labs: Applicability to Other Diagnostics

12:22 Research Opportunities and Clinical Trials

16:22 Community Engagement and Public Health Initiatives

19:54 Understanding Interoperability and Integration Challenges

27:10 Partnerships and Future Directions in Healthcare

This conversation explores the transformative potential of AI in healthcare, emphasizing the importance of agentic AI, interoperability, and the need for a shift in medical education. The speakers discuss the challenges and opportunities presented by AI technologies, the necessity of upskilling healthcare professionals, and the economic models that must evolve to support these changes. They highlight the importance of viewing information as an asset and the role of AI in enabling personalized, longitudinal care for patients.

Takeaways

• There's always a new challenge to overcome in healthcare.
• Mistakes often provide the best learning opportunities.
• Agentic AI is set to transform healthcare significantly.
• AI should enhance, not replace, human interaction in care.
• 80% of clinicians' time is spent on administrative tasks.
• Interoperability is crucial for effective patient care.
• AI can synthesize vast amounts of data for better outcomes.
• Investment in healthcare needs to focus on outcomes, not just costs.
• Medical education must evolve to prioritize preventive care.
• AI can turn healthcare from episodic to longitudinal care.

Chapters

00:00 The Knothole Metaphor: Personal Drive and Motivation
02:57 Transformational Technology: The Impact of Agentic AI
05:38 AI in Healthcare: Redefining Roles and Responsibilities
08:43 Interoperability: The Key to Better Clinical Care
11:50 AI Integration: Upskilling and Workflow Automation
14:39 AI Native Applications: The Future of Healthcare Technology
17:42 Longitudinal Care: The Role of AI in Patient Management
20:32 Investment in Healthcare: Shifting Economic Models
23:37 The Future of Medical Education: A New Paradigm
26:31 Conclusion: The Bright Future of AI in Healthcare

Key Takeaways:

• Healthcare's Unique Business Model: Adam discusses the complexities of the healthcare industry, where the consumer often isn't the payer, creating unique challenges and opportunities for innovation.
• Investment Insights: Learn about the importance of grounded, data-driven forecasting and why over-promising can be a red flag for investors.
• The Role of Technology: Explore how technology can enhance healthcare delivery without replacing the essential human touch in patient care.
• Success Stories: Adam highlights successful investments, including Central Logic, which improved patient navigation and efficiency within health systems.
• Focus Areas: Discover Oakwood Circle Ventures' interest in digital health and medtech, emphasizing innovative solutions that improve healthcare delivery and patient outcomes.

Tune In:

In this conversation, Craig Hittle discusses the evolving nature of telemedicine, emphasizing that it should not be viewed merely as a transactional service. Instead, he advocates for a model that fosters long-term relationships between patients and healthcare providers, enhancing the overall quality of care delivered through digital platforms.

Takeaways

• Telemedicine is often misunderstood as purely transactional.
• The goal of telemedicine should be to build relationships.
• Long-term relationships with providers can improve patient care.
• Telemedicine can enhance accessibility to healthcare services.
• Establishing trust is crucial in telehealth interactions.
• Patients should feel connected to their providers through telemedicine.
• Digital health platforms can facilitate ongoing care.
• The future of healthcare includes a blend of in-person and virtual visits.
• Effective communication is key in telehealth.
• Telemedicine can lead to better health outcomes when used correctly.

Chapters

00:00 Introduction to Health Tap and Primary Care Innovations
04:16 The State of Primary Care in America
05:08 The Rise of Telemedicine and Its Impact
09:30 Telemedicine: A Shift in Patient Care Dynamics
12:39 Understanding the Durbin Report and Its Implications
15:35 Chronic Condition Management and Telehealth
17:58 The Role of AI in Enhancing Patient Care
21:11 Genomic Information in Primary Care
24:16 The Future of Telemedicine and Patient Relationships
28:26 Challenges and Opportunities for Primary Care Doctors
34:08 Value-Based Care: Aligning Incentives for Better Health

In this episode of Boombostic Health, host Bradley Bostic interviews Sherri Ozawa, a leading expert in patient blood management. They discuss the evolution of blood transfusion practices, the importance of viewing blood as a vital organ, and the economic implications of blood management.

Sherri shares insights from her journey into healthcare, the role of technology in optimizing blood health, and global perspectives on blood safety. The conversation underscores the need for a shift in blood management practices and highlights the potential for improving patient outcomes through data-driven decisions. Discover how understanding blood as a vital organ can transform healthcare practices and improve patient outcomes.

Key Takeaways

• The evolution of blood transfusion practices

• The economic implications of blood management

• The role of technology in optimizing blood health

• Global perspectives on blood safety

Chapters

• 00:00 Introduction to Patient Blood Management

• 02:47 Sherri's Journey into Healthcare

• 05:02 The Evolution of Blood Transfusion Practices

• 09:07 Understanding Blood as a Liquid Organ

• 13:14 The Importance of Blood Health

• 16:23 The Role of Technology in Blood Management

• 19:14 Global Perspectives on Blood Management

• 21:23 Economic Implications of Blood Transfusion

• 25:57 Connecting Blood Management to Patient Outcomes

• 27:59 The Future of Patient Blood Management

Episode 23: Accelerating Healthcare with Data Insights

Join us for an insightful conversation on Boombostic Health as Bradley Bostic sits down with Bridget Wegner, Director of Partnerships at Clarivate. Bridget shares her journey from aspiring forensic scientist to a leader in laboratory medicine and data analytics. Discover how her passion for diagnostics and data is driving advancements in healthcare.

Watch on YouTube

Key Topics:

• The pivotal role of data in accelerating healthcare, focusing on how laboratory information can be leveraged for predictive and preventative care.

• Clarivate's strategic focus on genomics for rare disease research, emphasizing the need for precision in data use cases.

• The critical importance of informed consent in data sharing, ensuring patients are aware of how their data is used for secondary research.

• Bridging the gap between laboratories and pharmaceutical companies to enhance patient outcomes, addressing the challenges of data quality and interpretation.

• Exploring the challenges and opportunities in leveraging diagnostic data, including the nuances of laboratory testing and the business landscape.

Highlights:

• How Clarivate is strategically partnering with labs and pharma to unlock insights from diagnostic data, transforming it into actionable information.

• The impact of genomic data on drug development and patient care, with examples of how specific genetic variants are used in diagnostics.

• Addressing patient data privacy and informed consent, highlighting the importance of clear communication and compliance in data partnerships.

Tune in to learn how data insights are transforming healthcare and the future of diagnostics.

• Pam Pure emphasizes the need for a male-focused approach in fertility treatments.
• Two-thirds of infertility cases involve a male factor, highlighting the importance of male evaluations.
• Early testing for males can significantly reduce the time couples spend trying to conceive.
• Insurance coverage for male reproductive health is becoming more accessible, changing the landscape of fertility treatments.
• Posterity Health aims to create a holistic approach to male health, integrating it with female fertility journeys.
• Testosterone therapy can negatively impact sperm production, making it crucial for men to seek specialized care.
• Behavioral factors, such as lifestyle choices, play a significant role in male fertility and overall health.
• The company aims to be a trusted resource for men navigating their reproductive health.
• Holistic men's health encompasses more than just fertility; it includes overall well-being and health optimization.
• The conversation highlights the interconnectedness of male and female reproductive health.

Guest: Chris Leeuw, CEO and Founder of NeuroHope

Topic: Transforming a critical gap in neurohealth healthcare into a thriving nonprofit.

🎥  Watch on YouTube: https://youtu.be/y03xqInUTO4

Summary:

Welcome to Boombostic Health, where we challenge healthcare norms with bold ideas and transformative stories. In this episode, host Bradley Bostic engages with Chris Leeuw, founder of NeuroHope, to explore his extraordinary journey from personal tragedy to entrepreneurial triumph.

• Resilience and Innovation: Chris's story is a testament to overcoming adversity. After a devastating accident left him paralyzed, he defied the odds by regaining mobility and revolutionizing spinal cord injury care.

• Healthcare Transformation: Discover how Chris identified a critical gap in healthcare and turned it into a thriving nonprofit, NeuroHope, offering hope and recovery to hundreds.

• Community and Economics: Dive into the complexities of healthcare economics and the indispensable role of community support in sustaining long-term care.

• Future of Neurorehabilitation: Chris shares insights on the groundbreaking work at NeuroHope and the essential need for long-term care solutions.

Tune in to be inspired by a story of human spirit and the relentless pursuit of change in healthcare. Don't miss this compelling episode that will challenge your perspective on resilience and innovation.

First, Dr. Justin Bekelman on rebuilding oncology around the patient with in-home and value-based care. Then, IU Health CEO Dennis Murphy on rebuilding a 16-hospital system around values and platforms that scale.

This is Boombostic Health Encore - our most relevant moments, cut for leaders short on time.

In this Encore:

- Why cancer care fails after 5 PM and what fixes it

- Why coordination alone is not enough - you have to be able to act

- How to move from a rules-based organization to a values-based organization

- Platform solutions that solve 100 problems vs point solutions that solve one

Chapters:

00:00 Why this Encore - care doesn't end at discharge

02:30 Part 1 - Dr. Bekelman on value-based oncology and in-home support

09:00 Bridge - from bedside proof to system playbook

09:30 Part 2 - Dennis Murphy on values-based leadership and platforms

14:30 What this means for healthcare leaders

Recorded live at ViVE 2026 in Los Angeles, Bradley Bostic sits down with Dave Newman (Digital Health) and Brad Reimer (CIO) from Sanford Health to explore how one of the nation's largest rural health systems is redefining care delivery.

Serving 2 million patients across 320,000 square miles, Sanford Health is proving that innovation doesn't only happen in major urban health systems. From virtual care infrastructure funded by a $350M investment to AI tools that restore the human connection between doctors and patients, Sanford is building a new model for rural healthcare.

The conversation explores how virtual care, AI, and data governance are helping clinicians spend more time with patients while expanding access across the Upper Midwest.

A key insight: technology works best when it returns healthcare to what matters most — the relationship between doctor and patient.

What if detecting cancer was as simple as giving a urine sample? No needles. No surgery. No fear.

In this episode of Boombostic Health, host Bradley Bostic sits down with Curtiss McNair Jr., VP of Operations at PanGIA Biotech, to unpack one of the most groundbreaking medical innovations in decades: a urine test powered by AI that can detect multiple cancers with jaw-dropping accuracy.

But this conversation isn't just about the science. It's also about the leadership and vision needed to take innovations like this from the lab to real-world patients.

🔑 Key Takeaways

• The Breakthrough: How PanGIA's urine test achieves 96% sensitivity, 74% precision, and an 84% F1 score in early cancer detection.

• Why It Matters: 2 out of 3 biopsies for prostate and brain cancer come back benign. This test could eliminate unnecessary, invasive procedures.

• Global Impact: Why PanGIA launched first in India, and how cultural barriers to invasive exams are driving adoption.

• AI in Action: How artificial intelligence identifies subtle biomarker patterns invisible to the human eye.

• The Leadership Gap: Why building better healthcare depends not just on new technology, but on bold leaders willing to drive systemic change.

🌍 Why You Should Listen

Cancer has touched nearly every family, and early detection is the single most powerful tool we have to save lives. This episode blends cutting-edge science, practical healthcare realities, and leadership wisdom that every innovator, clinician, and patient advocate needs to hear.

AI can make healthcare faster. But can it also make the patient experience more human?

Live from ViVE, Marcus Gordon sits down with Ed Flores, VP of Business Development at Teleperformance, to examine how agentic AI is transforming patient and member engagement behind the scenes.

From detecting fear in an oncology patient's voice to delivering real-time coaching, sentiment analysis and next-best actions, Ed explains how human-in-the-loop AI can help healthcare teams respond faster without removing the human judgment patients need.

They discuss:

• How AI is improving scheduling and patient engagement

• Why human-in-the-loop models can accelerate healthcare adoption

• The rapid rise of autonomous AI agents

• How workforce shortages are driving operational change

• Security, interoperability and responsible AI deployment

• Teleperformance's expanding role in clinical and diagnostic support

The central takeaway: efficiency alone is not enough. Healthcare AI must understand the moment, protect the patient and help people make better decisions.

Subscribe to Boombostic Health for executive conversations spotlighting diagnostics, healthcare's intelligence layer.

Chapters

00:00 Live from ViVE
01:41 Human-in-the-loop AI
02:05 Improving the patient journey
03:19 AI that listens and responds
04:40 Overcoming healthcare's adoption barriers
07:04 The rise of autonomous AI agents
07:57 Security and interoperability
08:47 Expanding clinical and diagnostic support

Most healthcare technology targets patients after they become seriously ill. Rick Goddard believes agentic AI could create an even larger opportunity: helping primary care teams engage healthy and rising risk patients before their conditions escalate. 

Recorded live at ViVE, Boombostic Health host Marcus Gordon sits down with Rick, SVP of Market Alliances at Lumeris, to explore how agentic AI could extend the reach of primary care physicians, strengthen prevention and help accelerate the shift toward value based care.

Rick introduces Tom, Lumeris' primary care agentic orchestration platform. Designed as a direct extension of the physician and care team, Tom can engage patients between visits, gather information that may otherwise be missed and help connect fragmented healthcare data.

The conversation also examines the trust, security and change management required to move clinical AI from promising technology to meaningful adoption.

In this episode:

• Why the primary care physician must remain at the center of AI enabled care

• How Tom extends the physician's reach between patient visits

• Why physician and patient trust will determine clinical AI adoption

• How agentic AI could make prevention possible at a much larger scale

• Why Lumeris selected Google Cloud to support its AI infrastructure

• What healthcare startups can learn from Lumeris' 20 year evolution

• How agentic AI could change the economics of value based care 

CHAPTERS

00:00 Welcome from ViVE

01:08 The evolution of Lumeris

03:35 Introducing Tom

04:50 Keeping primary care at the center

05:58 The realities of clinical AI adoption

08:22 Extending care beyond the physician visit

09:31 Security, data and Google Cloud

10:32 Lessons for healthcare innovators

12:05 Scaling prevention with agentic AI

14:02 A potential economic shift in healthcare 

FEATURED GUEST

Rick Goddard SVP of Market Alliances at Lumeris

Subscribe to Boombostic Health for conversations with the leaders shaping diagnostics, AI and the future of healthcare.

 #AgenticAI #PrimaryCare #HealthcareInnovation

In this episode of Boombostic Health, we dive into the transformative ideas shaping the future of healthcare. The conversation covers key topics such as healthcare innovation, the power of local partnerships, and the role of data-driven strategies in diagnostics.

We also explore how labs are driving the shift toward preventative care and discuss the complexities of mergers and acquisitions in the healthcare space. From data management to compliance and revenue streams, the episode highlights the importance of strategic integration to improve patient outcomes and operational efficiency.

Watch full episode on YouTube

Key Takeaways

• Personal experiences often spark meaningful healthcare innovation.

• Building strong local relationships is essential for impactful healthcare partnerships.

• Leveraging data and predictive analytics can unlock growth in diagnostic services and improve outcomes.

• Preventative healthcare is the cornerstone of longevity and quality of life.

• A deep understanding of revenue streams is critical for successful healthcare M&A.

• Data privacy and compliance are non-negotiable in healthcare transactions.

• Effective post-merger integration is vital for long-term success.

• Collaboration and clear communication drive successful healthcare partnerships.

• The future of healthcare lies in prioritizing patient outcomes and operational efficiency.

In this episode of Boombostic Health, host Bradley Bostic sits down with Lathe Bigler of First Data Bank to unpack why e-prescribing hasn't evolved in decades, how opaque pricing keeps patients in the dark, and why the next wave of pharmacy network innovation could flip the power dynamic back to patients.

💡 What We Cover:

• Why patients are frustrated with rising prescription costs
• How transparency empowers patients with real choices
• What most people don't know about paying cash for prescriptions
• How e-prescribing networks can break pharmacy bottlenecks 
• The role of technology in creating competition — and lowering costs 
• This isn't just about convenience. It's about rebuilding trust in the healthcare system.

Chapters

00:00 Introduction to Boombostic Health and Conference Atmosphere

08:23 Innovations in e-Prescribing Networks

14:59 The Importance of Transparency and Choice in Healthcare

#boombostichealth #healthcareinnovation #PrescriptionTransparency #digitalhealth #patientempowerment #healthcaretechnology #prescriptioncosts #FirstDataBank #healthcaretechnology #healthcareleadership

Can AI-powered remote care help close the gap without sacrificing safety or human judgment?

Live from ViVE, Marcus Gordon sits down with Oren Nissim, CEO and Co-Founder of Brook Health, to examine how technology and human care teams can extend chronic disease management into the home.

From hypertension and diabetes to heart failure and complex kidney conditions, Oren explains how Brook uses AI to support monitoring, patient engagement, recommendations, and follow-up between visits.

But the technology is only one part of the solution. Scaling remote care will require responsible AI guardrails, sustainable reimbursement, secure data exchange, provider participation, and evidence that these models produce meaningful results.

They discuss:

• Why an aging population and shrinking provider workforce are creating an urgent access challenge
• How remote care can extend the reach of providers serving Medicare patients
• Where AI can support monitoring, engagement, and evolving care plans
• Why clinical interventions require stronger safeguards than general wellness tools
• How reimbursement and policy could accelerate care at home
• Why security, compliance, and interoperability remain essential
• Why healthcare AI companies must show results, not simply promote use cases

The central takeaway: AI will not replace the people delivering chronic care. It can extend their reach, but only when innovation is paired with human oversight, sustainable payment, strong safeguards, and measurable outcomes.

Subscribe to Boombostic Health for candid conversations with the leaders shaping the future of diagnostics, technology, and patient care.

CHAPTERS

00:00 Live from ViVE with Oren Nissim
00:49 Extending chronic care into the home
01:41 The aging population and provider shortage
02:36 Balancing AI innovation with patient safety
04:48 How reimbursement could expand remote care
06:30 Turning patient data into an evolving care plan
07:02 Building guardrails for clinical AI
08:06 Security, compliance, and data exchange
08:51 Why healthcare AI must prove results

What if women could know — years in advance — when perimenopause and menopause will begin?

In this episode of Boombostic Health, host Bradley Bostic talks with Nich Gentry and Dr. Lizellen La Follette of Life Ahead, a groundbreaking company combining ultrasound, personalized data, and validated science to give women a clear picture of their reproductive timeline.

You'll learn:

• Why ovarian aging is the "canary in the coal mine" for overall health.

• How early menopause prediction could transform bone health, cognitive health, and preventive care.

• The science behind Life Ahead's algorithm — and why it's a breakthrough for both patients and clinicians.

• Why women's health research has been historically underfunded and how that's changing.

• The entrepreneurial challenges of building a science-backed health tech company.

Whether you're in healthcare, innovation, or simply care about the future of women's health, this conversation will leave you inspired — and rethinking what's possible in preventive care.

Listen now to learn how data, science, and proactive healthcare can rewrite the future for millions of women.

Key Moments

00:00 – Why Proactive Healthcare Matters
Shifting from reactive to proactive care in women's health.

01:14 – Meet Life Ahead
Nich and Dr. Lizellen share their mission to close the women's health gap.

04:11 – Understanding Ovarian Aging
Why ovaries age faster than most organs and what it means for overall health.

08:16 – Perimenopause Explained
What it is, symptoms, and why timing matters.

10:11 – The Cost of Waiting
How early menopause prediction could save money and improve health outcomes.

12:41 – The Science Behind the Tool
From NSF funding to Yale mathematicians — the breakthrough research journey.

14:43 – The Startup Rollercoaster
Highs, lows, and challenges of building a new category in healthcare.

27:17 – WHOOP, Fitness, and Sleep
Why tracking recovery and lifestyle metrics is part of better healthcare.

30:17 – Looking Ahead
Envisioning the future of women's health through predictive technology.

Mental health, early-onset cancer, autoimmunity—much of that risk is already visible in the gut years before a diagnosis code ever hits the chart. Most care models, benefits designs, and longevity strategies simply don't account for it.

In this episode of Boombostic Health, I sit down with Paul Denslow, CEO & co-founder of Intus Bio, to dig into how GutID turns the microbiome into hard infrastructure: high-resolution gut data, a score you can track, and a way to see whether your interventions are actually moving risk—not just spend.

In this episode, we cover:

• Why microbiome disruption often precedes mental health issues and cancer

• How GutID converts millions of bacterial data points into a single, trackable gut score

• Why behavioral health and functional practitioners have been early adopters

• The problem with "just take a probiotic" in the absence of baseline gut data

• How AI + high-resolution microbiome testing open a real prevention window

• What a serious prevention and longevity strategy looks like when gut data is included

If you're responsible for care delivery, benefits strategy, or long-term risk, ignoring this data layer is no longer a neutral decision.

Watch the full conversation to see why mental health, cancer, and your "bacterial you" belong at the center of modern prevention.

About our guest:

Paul Denslow is the CEO and co-founder of Intus Bio, the company behind GutID. With a background in finance and big data, Paul partnered with co-founder Mark Driscoll, a pioneer in next-generation sequencing, to build a platform that treats the microbiome as a hard data problem—not a mystery. Intus Bio's GutID test and Titan 1 platform are used by clinicians and practitioners to generate high-resolution microbiome data that can be translated into actionable prevention and disease insights.

Links & Resources:

Learn more about GutID: https://www.gutid.com/collections/all

Learn more about Intus Bio: https://www.intusbio.com/gutid

Watch more Boombostic Health episodes: https://www.boombostichealth.com/podcast